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ABSTRACT
Cyclophilins are ubiquitous enzymes that are involved in protein folding, signal transduction, viral proliferation, oncogenesis, and regulation of the immune system. Cyclophilin A is the prototype of
the cyclophilin family. We use molecular dynamics to describe the catalytic mechanism of cyclophilin A
in full atomistic detail by sampling critical points along the reaction coordinate, and use accelerated molecular dynamics to sample cis-trans interconversions. At these critical points, we analyze the conformational space sampled by the active site, flexibility of the enzyme backbone, and modulation of binding
interactions.We use Kramer’s rate theory to determine how diffusion and free energy contribute to
lowering the activation energy of prolyl isomerization. We also find preferential binding modes of several cyclophiln A inhibitors, and compare the conformational space sampled by inhibited cyclophilin A to
the conformational space sampled during wild-type interactions. We also analyze the mechanism of the
next family member cyclophilin B in order to probe differences in enzyme dynamics and intermolecular
interactions that could possibly be exploited in isoform-specific drug design. Our results indicate that

cyclophilin proceeds by a conformational selection binding mechanism that manipulates substrate
sterics, electrostatic interactions, and multiple reaction timescales in order to speed up reaction rate.
Conformational space sampled by cyclophilin when inhibited and when undergoing wild-type interactions share significant similarity. Cyclophilins A and B do have notable differences in enzyme dynamics,
due to variation in intramolecular interactions that arise from variation in primary structures. This work
demonstrates how computational methods can be used to clarify catalytic mechanisms.

INDEX WORDS: Proline cis/trans isomerization, Cyclophilin A, Cyclophilin B, Enzyme catalysis, Enzyme
dynamics, Enzyme isoforms, Kramer’s rate theory, Accelerated molecular dynamics, Conformational selection, Structure based drug design, Cyclophilin inhibition, Drug docking, Principal
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1

INTRODUCTION
Our research group studies the dynamics and reaction mechanisms of several types of mole-

cules and biomolecules using theoretical biophysical chemistry, including DNA, ribozymes, enzymes, and
smaller medicinal compounds. The focus of my graduate work is understanding enzyme function, namely, the enzyme cyclophilin A (CypA). In the same way that biology is the study of life, chemistry is the
study of matter, and physics is the study of the motion of matter through space and time. At the crossroads of chemistry and biology was birthed the field of biochemistry in the 20th century, which began to
give insight into the chemical reactions that occur within living organisms – most importantly the human
body and the pathogens that can invade it. The crossroads of chemistry and physics provided us with the
knowledge of how heat, work, organization, molecular interactions, and molecular motions affect the
energy required for chemical reactions to occur. Scientists began to learn how to quantitatively and
qualitatively express chemical reactions of interest; however, these quantitative descriptions are often
tedious and required multiple calculations for manual proof or demonstration of concept.
The invention of computers in the mid 20th century was the first transition from manual to automated calculations. The computer became the fundamental tool for molecular dynamics (MD), and
relieved much of the labor required for these mathematical proofs. The pioneers of molecular dynamics
began to publish results in the late 20th century, modeling ideal and real molecular interactions.(1) The
first molecular dynamics simulation of a protein was successfully implemented into the literature in
1977,(2) revealing the plasticity and dynamical nature of biomolecules, the molecules that sustain our
life. As computer memory and speed began to increase over time, theoretical scientists began to study
more complex systems of interest such as DNA and proteins. While experimental in vitro techniques
provided a way to study biomolecules on a macroscopic scale, theoretical in silico techniques such as
molecular dynamics provided a means to study biomolecules at the atomic level.
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The development of theoretical science also provided a way for scientists to validate their predictions in alignment with experimental results. The theoretical approaches yield an idealized, modeled
environment while the environment of experimental approaches is provided by nature. Success in experimental endeavors requires extensive knowledge of scientific techniques as well as their potential
errors and safety hazards. Although errors can be minimized, they cannot be completely avoided; even
our equipment has inherent error that reveal how precise our measurements are. The amount of control that we introduce into theoretical methods by algorithm design is based on our prior knowledge of
chemical behavior and is often times compared to the results we obtain from experimental procedures.
Moreover, scientists began to study dynamics of chemical and biochemical systems at timescales previously inaccessible by experimental techniques, down to the femtosecond. Being able to study dynamics
on significantly faster timescales unfolds aspects of reaction mechanisms that could not be effectively
characterized using in vitro or in vivo techniques.

3
2

INTRICATE COUPLING BETWEEN CYCLOPHILIN A DYNAMICS AND SUBSTRATE TURNOVER
The importance of enzymes in biology cannot be overstated. Enzymes are critical to a broad

range of functions, including metabolism(3), gene regulation(4), cell survival(5), intracellular communication(6), and hormone regulation(7). They catalyze specific biochemical reactions, increasing reaction
rates by many orders of magnitude to more biologically relevant timescales. Enzymes can act to form or
break covalent bonds, perform acid-base chemistry, transfer functional groups, and switch configurations around bonds to yield isomers(8-10). Certain enzymes can perform these functions alone, while
others need cofactors or prosthetic groups to assist in the catalytic function. Fully understanding the
mechanism of action of enzymes could provide valuable insights into engineering proteins and designing
new drugs.
In vitro experiments have provided valuable insights into the mechanisms of enzymes(11). However, detailed atomistic understanding of the mechanism along the catalytic pathway is not always possible with current experimental techniques. Therefore, computational simulations are routinely used to
complement experiments(12), usually starting from well-characterized atomic x-ray crystal structures.
Nonetheless, classical MD presents several challenges in studying enzyme mechanisms with catalytic
turnover times in the millisecond timescale. In addition to the sub-microsecond timescale limitation, MD
cannot be used to study chemical reactions involving bond formation or breakage without the use of
more demanding hybrid quantum mechanical methods. As of this writing, it is not believed possible to
directly simulate most enzymatic reactions without using some form of course-graining or advanced
sampling techniques.
Peptidyl-prolyl cis-trans isomerases (PPIases) are a class of enzymes that take part in many cellular processes and catalyze their reactions without any bond formation or breakage. This characteristic
makes them tractable and ideal to study using classical MD. PPIases catalyze cis-trans isomerization of
backbone peptidyl-prolyl ω-bond angle. The cis, trans, and transition state configurations of the sub-
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strate along the reaction coordinate are well defined at ω-bond angle values of 0˚, +180˚, and 90˚, respectively. Also, the cis-trans interconversion can be simulated directly using accelerated MD, without
any conformation bias, as was previously shown(13, 14). PPIases consist of cyclophilins, FK-506-binding
proteins, and parvulins(15). The tertiary structure of the catalytic domain of cyclophilins is structurally
conserved among all of the familial isoforms(16). Human cyclophilin A (CypA), this smallest prototypic
cyclophilin of ~18 human isoforms, is the most studied and characterized isoform(17). Uncatalyzed
prolyl cis-trans isomerization has an activation free-energy barrier of ~20 kcal/mol (~84 kJ/mol)(18) and
a half-life on the second timescale(19, 20). Human CypA speeds up the reaction rate from seconds to
milliseconds(21). CypA catalyzes the peptide bond of a -X-Pro- motif (where X is any amino acid), and
differences in catalytic turnover rates are mainly due to the identity of the amino acid in the X
position(21, 22).
Human CypA has a range of specific functions in vivo. The immunosuppressive drug cyclosporine A (CsA) binds to CypA, and the CypA-CsA complex inhibits calcineurin, suppressing the transcription
of cytokine genes by inhibiting calcineurin’s native phosphatase function(15). CypA is the first human
protein that has been found to be both enclosed within the HIV-1 virion and crucial for viral
replication(23, 24). An interaction between CypA and the HIV-1 capsid core protein, CAN, facilitates viral
replication by accelerating destruction of the capsid(24, 25). Hepatitis C virus also uses CypA to replicate
by forming a critical contact with the HCV NS5B RNA polymerase(26). A role of CypA in signal transduction involves regulating the function of the prolactin receptor in mammary cells, impacting the interaction of the prolactin receptor with Janus-activated tyrosine kinase(27). Also, CypA can form a complex
with interleukin-2-tyrosine kinase inside of Jurkat T-cells, which is disrupted upon addition of CsA(28).
Cyclophilins are also involved in protein folding (15)and oncogenesis(27, 29).
The exact catalytic mechanism of CypA is not fully understood. Several hypotheses have been
presented to explain the greater than five orders of magnitude speedup in prolyl isomerization by the
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enzyme(27, 30-35). It has been suggested that conformational heterogeneity that occurs during enzyme
catalysis provides the means by which an enzyme complements its substrate(36). Therefore, in order to
fully understand the mechanism of CypA, there is a need to fully understand how enzymes make use of
a large ensemble of conformations in recognition and catalysis at different points along the chemical
step. We have therefore simulated the substrate-free enzyme and enzyme-substrate complexes of the
cis, trans, and transition state configurations of the substrate – three important segments along the catalytic pathway. We have also carried out accelerated MD simulations on the enzyme-substrate complex
in order to freely sample cis-trans isomerization during catalysis and investigate the coupling between
the conformational dynamics of CypA and the chemical step. Altogether, we carried out >2 μs of MD
simulations in full atomistic detail, sampling conformational changes beyond the nanosecond timescale.
Moreover, these computational approaches provide a way to study the short-lived ensemble of conformations of the enzyme-substrate transition state complex. These studies provide further insight into the
importance of enzyme flexibility in catalysis, as well as the coupling between the chemical step and the
stabilizing polar and nonpolar intermolecular interactions.
2.1

Methods
All simulations were carried out using the AMBER 10 suite of programs(37) in explicit TIP3P wa-

ter(38) using the PARM99SB(39) modified version of the force-field parameters from Cornell et al. (40).
Additional modifications to the dihedral parameters for the peptide ω-bond angle were also employed
(41). A 1.58 Å resolution x-ray crystal structure with PDB:1AWR was used for the simulations (25). An
experimentally well-studied substrate analog, Ace-Ala-Ala-Pro-Phe-Nme (AAPF), was used in these studies (21, 22, 33, 34, 42-45). The Ace-AAPF-Nme substrate analog was introduced by keeping common
backbone and side-chain atoms of the substrate analog (HAGPIA) in the PDB file and adding the missing
atoms using the xleap module in AMBER. The complex was then solvated with ~5500 TIP3P water molecules and was neutralized with four chloride ions. The potential energy of the system was initially mini-
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mized for 1000 steps with a harmonic constraint of 100 kcal/mol/Å2 applied to the atoms of the protein,
followed by two short (400-ps) MD simulations with harmonic constraints of 50 kcal/mol/Å2and 25
kcal/mol/Å2, respectively, applied to all of the atoms of the protein. The system was then equilibrated
for an additional 200 ps without any constraints using the isothermal-isobaric ensemble at 300 K and 1
bar. The pmemd module in AMBER 10 was used to carry out all of the conventional MD simulations. An
integration time step of 0.002 ps was used to integrate Newton’s equation of motion.
The SHAKE algorithm (46) was used to restrain all bonds involving a hydrogen atom during the
simulations. Langevin dynamics was used to maintain the temperature at 300 K with a collision frequency of 1 ps-1. This temperature and a constant pressure of 1 bar were used throughout all simulations.
The long-range electrostatic interactions were treated using particle-mesh Ewald summation (47-49).
The ω-bond angle of the substrate in the transition state complex was maintained at ~90˚ using a flat
bottom-well torsional restraint with a force constant of 1000 kcal/mol/Å2 between 89˚ and 91˚. Restraints were not required to maintain the substrate in the trans and cis configurations in their enzymesubstrate complexes, because a high barrier separates the two low-energy states. The substrate in the
crystal structure was in the trans configuration. Thus, the cis configuration of the substrate was equilibrated with the same torsional restraint in order to shift the substrate from the trans configuration to
the cis, and subsequently simulated with no restraint.
The aggregate simulation time for all of the conventional MD simulations of substrate-free CypA
and the enzyme-substrate complexes exceeded 1.5 μs. Four independent simulations were carried out
for each enzyme-substrate complex. Each simulation was carried out for at least 110 ns. The first 10 nanoseconds were discarded as part of the equilibration phase. One long 350-ns simulation was carried
out on substrate-free CypA, using a similar setup and equilibration procedure as was done for the substrate-bound complexes.
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All accelerated MD simulations (50) were carried out using a modified version of the pmemd
module in AMBER 10, in order to accelerate the rate of cis-trans isomerization of the substrate while in
complex with the enzyme. Eight independent accelerated MD simulations were carried out for a total of
~1 μs of simulation time. The total torsional potential of the substrate was selectively boosted(13), using
a boost energy, E, of 60 kcal/mol above the average total dihedral energy calculated after equilibration
and a tuning parameter, α, of 10 kcal/mol. Each configuration was reweighted using the strength of the
Boltzmann factor of the bias potential energy, eβΔV(r), calculated on-the-fly during the simulation to calculate the probability distributions(51).
Principal component analysis (PCA) was carried out using the ptraj module in AMBER (37). The
implementation of this method has been extensively discussed (52-56), and ptraj was used to calculate
and diagonalize the covariance matrix. The ptraj module was also used to calculate the torsional angles,
root-mean-square fluctuations, and hydrogen-bonding distances. For residues containing equivalent δcarbons (such as Leu or Phe), the Cδ1 atom was selected when measuring the torsional angle. The binding free energies were estimated using the Molecular Mechanics/Poisson-Boltzmann Surface Area approach (57, 58). The relative changes in translational, rotational, and conformational entropies were
assumed to be negligible in estimating the relative binding free energies.
2.2

Conformational selection in CypA recognition during catalysis
In general, conformational selection (59-62) and induced fit(63) can be used to describe the

mechanism of enzyme-substrate recognition. Conformational selection implies that equilibria between
weak- and tight-binding conformations of the substrate-free enzyme exist before substrate binding,
whereas substrate binding is a prerequisite for the formation of a tightly bound enzyme-substrate complex in the induced-fit mechanism(64). However, these two mechanisms are limiting extremes for dynamical systems, and it is difficult to ascribe either one as the sole contributor to biomolecular recognition(61, 65). Also, these two mechanisms characterize conformational changes in enzymes with little
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regard given to conformational changes in the substrate. It has been previously noted that the freeenergy landscape of the enzyme and substrate are transformed upon complex formation(61). Thus, variation in the conformation of the substrate should also be considered when describing the conformational heterogeneity of the complex because the conformations of the enzyme can affect those of the
substrate, and vice versa.
We have used principal component analysis (PCA) to characterize the mechanism of recognition
of CypA upon binding the cis, trans, and transition state configurations of the substrate. PCA allows us to
project the conformational phase space sampled by the active site residues of the substrate-free and
substrate-bound enzyme using a reduced set of degrees of freedom. It helps us to determine if the conformations of the active site residues of the substrate-free enzyme can effectively bind the substrate by
revealing similarities between substrate-free and substrate-bound ensembles of enzyme conformations
(Fig. 1). Active site residues of CypA consist of Arg 55, Phe 60, Met 61, Gln 63, Ala 101, Asn 102, Ala 103,
Phe 113, Leu 122, and His 126. These residues were selected because they are no more than 4 Å away
from the peptide ω-bond angle and form the binding cavity for the substrate. Also, most of these residues are fully conserved across species and have been identified as participating in substrate turnover
(66).
Fig. 1 shows that the active site residues of substrate-free CypA sample a large conformational
space involving several rotameric states (Fig. 2 and Fig. A1). Upon binding the substrate, the active site
residues of CypA lose a tremendous amount of conformational freedom that was present in the substrate-free enzyme. The phase space sampled by the active site residues of the enzyme-substrate complexes in the cis and trans configurations (ground states) of the substrate is slightly broader than that of
the transition state complex. The conformational space of the transition state ensemble is compact,
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Figure 1
Figure 1. Principal component analysis (PCA) of free CypA and CypA enzyme-substrate complexes.
The top three dominant motions of the ten active site residues are shown, with each data point representing a
different conformation of the active site. The free enzyme is depicted in black, and trans complex is depicted in
red, the transition state complex is depicted in green, and the cis complex is depicted in blue. The enzymesubstrate complex is also shown with the hydrophobic active site residues in white surface. The active site residues
(Arg 55, Gln 63, and Asn 102) and Trp 121 that form hydrogen bonding interactions with the substrate are shown
with stick representation. The substrate is shown in yellow.

10
with few differences in the enzyme-substrate intermolecular interactions from one conformation to the
other. These enzyme-substrate intermolecular interactions involve several key hydrogen bonds, as
shown in Fig. 1D. These well-optimized hydrogen bonds localize the transition state ensemble of the
enzyme conformations to a single region of phase space, as we show later. It can be seen that the active
site of the substrate-free enzyme also samples the majority of the transition state conformations (Fig.
1).
The active site of the enzyme does not necessarily have to be induced to some exclusive conformations for catalysis to occur. The active site conformations of the ground-state complexes overlap
quite well with each other, while the transition state shares a smaller subset of conformations with the
ground states. The substrate-bound active site conformations of the enzyme are subsets of that of the
substrate-free enzyme conformations based on the top three principal components (Fig. 1 and Fig.
A2)that represent ~70% of the motions of the top 10 principal components of the active site residues
(see Fig. A3). The connection between the substrate-free and substrate-bound active site conformations
is indicative of an existing equilibrium between weak- and tight-binding conformations of the enzyme.
Localization of the active site residues of the bound ensembles is characteristic of a population shift toward a subset of the substrate-free enzyme conformations. The results suggest that CypA has evolved to
complementarily shift its active site conformation alongside the configuration of the substrate with only
slight changes to the rotameric state of the active site residues as the reaction progresses. Whether
CypA binds the substrate in the trans, transition state, or cis configuration, the needed enzyme conformations already exist in the ensemble of the substrate-free enzyme. Thus, the binding mechanism of
CypA is predominantly conformational selection, as was previously suggested by NMR studies (42, 67).
Examining the rotameric states of the active site residues in the substrate-free and the different
substrate configurations of the substrate-bound CypA suggests similar conclusions (Fig. 2). In general,
each ensemble of the bound complexes has its own unique distribution of rotamers for the active site
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residues. Various intramolecular and intermolecular interactions in the enzyme affect the conformational preference of the active site residues, which are also dependent on the state of the substrate. The
rotamers sampled by the active site residues of the substrate-free enzyme overlap with the rotamers
sampled by the substrate-bound enzyme complexes, also demonstrating that the bound conformations
of the enzyme are a subset of the free enzyme conformations. Active site residues that form hydrogenbonding interactions with the substrate tend to sample more rotameric states than hydrophobic residues. Unlike the hydrophilic residues, the hydrophobic residues in the bound states of the enzyme predominantly sample a single rotameric state and are less sensitive to the configuration of the substrate.
The most flexible active site residues are Arg 55, Gln 63, and Asn 102 – three residues that form
key hydrogen-bonding interactions with the substrate (Fig. 1D). Arg 55 has been shown to be important
for substrate recognition and catalysis by forming a bifurcated hydrogen bond with the carbonyl oxygen
of proline in the substrate (13, 33, 35). Gln 63 and Asn 102 also participate in hydrogen-bonding interactions with the substrate. However, only the hydrogen-bonding interactions between residues Arg 55 and
Asn 102 and the substrate have been identified as being important in stabilizing the transition state(33).
The backbone amine group of Asn 102 forms a hydrogen bond with the carbonyl oxygen of Ala in the Ala-Pro- motif only in the transition state and cis enzyme-substrate complexes. The side chain amide
group of Gln 63 forms a hydrogen bond with the carbonyl oxygen of the Ala residue preceding the -AlaPro- motif of the Ace-Ala-Ala-Pro-Phe-Nme substrate analog used in this study.
Phe 113 sits at the base of the proline-binding pocket and has been suggested to play a key role
in catalyzing cis-trans isomerization (42). Phe 113 can rotate in the free enzyme, and rotation to the minor rotameric state was suggested to be coupled to the catalytic step (42). Our studies suggest that,
once the substrate binds to the enzyme, the side chain of Pro in the substrate pushes directly against
the phenyl group of Phe 113. This keeps Phe 113 localized to the same rotameric state regardless of the
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Figure 2
Figure 2. Probability distributions of backbone torsional angles of some active site residues in free and bound
CypA.
Measurements are shown for the free enzyme (black) and enzyme-substrate complexes when the substrate is in
the trans (red), transition state (green), and cis (blue) configurations. The χ1 angle corresponds to atoms N-Cα-CβCγ and χ2 corresponds to atoms Cα-Cβ-Cγ-Cδ.
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conformation of the substrate (Fig. 2. and see Fig. A1). The minor rotameric state of Phe 113 seems to
obstruct the proline-binding pocket. Interestingly, the less active Ser99Thr mutation of CypA was shown
to increase the population of the minor rotameric state of Phe 113, which sits on top of Ser 99 (42). Another hydrophobic residue, Leu 122, in the active site forms intermolecular contact with the substrate in
the proline-binding pocket and predominantly samples only one rotameric state in all of the substratebound enzyme complexes (Fig. 2). In the substrate-free enzyme, Leu 122 participates in loose hydrophobic contacts with other active site residues in the proline-binding pocket, visiting more than one rotameric state.
2.3

Substrate binding alters the conformational dynamics of CypA beyond the active site
In addition to the conformational changes observed in the active site of CypA upon substrate

binding, the dynamics and fluctuations of the enzyme beyond the active site are also altered, as shown
in Fig. 3. Here, Fig. 3 shows the average percent-change in the root-mean-square fluctuations of the enzyme backbone atoms upon binding the substrate. Enzyme residues that become more localized upon
binding have positive change; conversely, residues that become more flexible upon binding have negative change. The loop region containing residues 75-85 becomes overall less flexible upon binding the
substrate in the cis and trans ground states (orange; Fig. 3). This region is part of a larger loop (residues
66-96) that has been reported to undergo fast conformational exchange in the substrate-free enzyme
(42). It appears that Lys 82 acts as a hinge for this loop, becoming more flexible upon binding the substrate in the transition state configuration. This residue has also been found to undergo significant deviation upon binding in other studies (31, 68). These results suggest that the motions of this loop have
significant impact on complex formation. Several residues of CypA within the loop region 75-85 are well
conserved across species, with the exception of residues Lys 76, Glu 81, and Glu 84 (66). Another loop
region (residues 147-155) exhibits smaller fluctuations upon substrate binding (violet; Fig. 3). This re-
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Figure 3
Figure 3. Average percent change in root mean square fluctuations upon substrate binding of CypA backbone
atoms.
Results are shown relative to the free enzyme for all 165 amino acids. A negative change signifies enhanced fluctuation upon substrate binding and a positive change signifies less fluctuation upon substrate binding. Red represents the trans complex, green represents the transition state complex, and blue represents the cis complex. Enzyme regions with significant changes are (a) residues 75 through 85 (orange), (b) residues 101 through 110 (cyan),
and (c) residues 147 through 155 (violet) are shown on the model structure on the right. The active site residues of
CypA are highlighted with transparent surface and stick representations.
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gion, in combination with the α-helix from residues 136-146, acts as a hinge region to the two β-sheets
contributing to the closed β-barrel fold. The stability of this loop region upon substrate binding suggests
that the two β-sheets become more compact in the enzyme-substrate complex and less likely to separate as much as would be expected in the breathing motions of the substrate-free enzyme.
Of particular interest is the loop region consisting of residues 101-110 (cyan; Fig. 3). This region
becomes more flexible upon substrate binding and most flexible in the transition state enzymesubstrate complex. Moreover, these residues are well conserved across different species (66) and have
been shown to contribute to the dominant motions of CypA (69). The motion of this loop may be critical
to catalytic turnover, and this motion may be required to introduce enough deviation to allow Asn 102
to form hydrogen bonds with the substrate. This hypothesis may be tested experimentally by modifying
the dynamics and flexibility of that loop to determine how the catalytic turnover rate is impacted. Very
few deviations are apparent in the backbone of the active site residues upon binding the substrate in
the different configurations, as opposed to the relatively large side-chain rearrangements that are observed. The results therefore suggest that the backbone of the active site in the substrate-free enzyme is
pre-organized to bind the substrate in its different configurations that requires rearrangements of several key side chains during catalysis. Also, many of these loop residues have been shown to contribute to
the top three vibrational modes of CypA (66, 68).
2.4

Intermolecular interactions are tightly coupled to the chemical step
It is well established that enzymes lower the free energy barrier of a reaction by stabilizing the

transition state during catalysis (10). However, it is not always clear as to how exactly this barrier reduction is achieved. In the active site of CypA, the conformations that complement the transition state are
very ordered, resulting in a low entropy, yet high affinity complex. This order is achieved due to key enzyme-substrate in intermolecular interactions. The key intermolecular interactions of CypA include the
hydrophobic contacts between the substrate and the active site cavity and the formation of several spe-
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cific enzyme-substrate hydrogen bonds (Fig. 1D). The smaller conformational space sampled by the active site residues of the substrate-bound complexes (as compared to the substrate-free enzyme) is a
result of the formation of these intermolecular interactions.
Initially, two main hydrogen bonds involving Arg 55 and Asn 102 of CypA were identified as being responsible for stabilizing the transition state relative to the ground state (13). These two hydrogen
bonds flank the proline residue of the -Ala-Pro- motif of the substrate analog. In this work, we have
identified at least four intermolecular hydrogen bonds between the enzyme and substrate that are
deemed to be important in stabilizing the transition state (Figs. 1D and 4). The bifurcated hydrogen
bond between the guanidinium group of Arg 55 and the carbonyl oxygen of proline in the -Ala-Pro- motif
of the substratein the -Ala-Pro- continually forms and breaks in the ground (cis and trans) states. However, this hydrogen bond is always well formed in the transition state complex and is almost never broken (Fig. 4 and see Fig. A4). While Arg 55 can undergo fast conformational changes in the free enzyme
(31), it becomes less mobile in the enzyme-substrate complexes, especially upon binding the transition
state.
Similarly, Gln 63 and Asn 102 are involved in several hydrogen-bonding interactions with the
substrate that are loosely formed in the cis and trans states, but well formed in the transition state. The
side-chain amide proton of Gln 63 forms a hydrogen bond with the carbonyl oxygen of the Ala residue
preceding the -Ala-Pro- motif of the substrate (Fig. 1D). This hydrogen-bonding interaction is difficult to
form in the trans and cis states. However, in the transition state, it is difficult to break (Fig. 4 and see Fig.
A4). The backbone amine group of Asn 102 forms a tight hydrogen-bonding interaction with the carbonyl oxygen of alanine in the -Ala-Pro- motif of the substrate in the cis and transition states, but not in the
trans state. We believe this tightly formed hydrogen-bond interaction between Asn 102 and the cis configuration is partly responsible for the higher binding affinity of the cis configuration over the trans
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Figure 4
Figure 4. Enzyme-substrate intermolecular hydrogen bonding interactions contributing to the transition state
stabilization of CypA.
Measurements are shown for the substrate in the (A) the trans, (B) the transition state, and (C) the cis configurations. Hydrogen bonds are measured from heavy atom to heavy atom. The magenta curve represents the contact
between the Arg 55 guanidinium carbon and the carbonyl oxygen of the substrate Pro. The royal blue curve represents the contact between the backbone nitrogen of Asn 102 and the carbonyl oxygen of Ala of the Ala-Pro motif.
The cyan curve represents the contact between the backbone oxygen of Asn 102 and nitrogen of Ala, also located
on the Ala-Pro motif. The orange curve represents the contact between the side chain amino nitrogen of Gln 63
and the carbonyl oxygen of Ala, preceding the Ala-Pro motif.
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configuration to the enzyme, as shown below and previously observed computationally (13) and experimentally (31, 67).
In the substrate-free enzyme, Arg 55 can move freely. In the enzyme-substrate complexes of the
cis and trans states, Arg 55 can either orient downward, interacting with the substrate; or upward (away
from the active site), interacting mainly with residue Asn 149 in a loop (violet; Fig. 3). In one out of the
four independent normal MD simulations carried out on the enzyme-substrate complex when the substrate is in the trans state, Arg 55 is consistently in the downward position, interacting with the substrate. In the other three simulations, Arg 55 spends most of the time upward, away from the active site
and substrate. In all of the independent normal MD simulations of the enzyme-substrate complex when
the substrate is in the cis state, Arg 55 sampled both downward and upward conformations. The interaction between Arg 55 and the substrate in the transition state complex was hardly ever broken in all four
independent normal MD simulations. The results suggest that the behavior of Arg 55 is sensitive to the
state of the substrate and changes along the catalytic pathway. To fully understand the conformational
preference of Arg 55, and other key residues, and determine how the intermolecular interactions are
coupled to the state of substrate during catalysis, we carried out accelerated MD simulations on the enzyme-substrate complex. Accelerated MD allowed us to observe the back-and-forth cis-trans isomerization of the catalytic process while sampling the conformational space of the enzyme.
The hydrogen-bonding interaction between Arg 55 and the substrate is coupled to the chemical
step along the reaction coordinate, ω, as can be seen in Fig. 5. Also, it is clear from Fig. 5 that, in the
trans state, Arg 55 has to overcome an energetic barrier of ~5 kcal/mol in order to switch between the
upward and downward conformers, unlike the cis configuration. This barrier is small in the cis enzymesubstrate complex, and Arg 55 in the transition state complex consistently stays in the downward position due to optimized contact with the substrate. These results are consistent in all eight, independent,
accelerated MD simulations that were carried out. Fig. 5 is an average of the eight independent runs.

19

Figure 5
Figure 5. Coupling between the intermolecular hydrogen bonding interaction of Arg 55 and the reaction coordinate (ω).
The strength and behavior of this interaction is coupled to the chemical step, and is sensitive to the ground state
conformation. The contour plot (right) is in kcal/mol. The interaction measured is shown on the left with a dashed
line. The Ala-Pro motif of the substrate is shown in the transition state configuration on the left with a dashed line.
The Ala-Pro motif of the substrate is shown in the transition state configuration, and the remaining residues of the
substrate are shown with a white stick representation. The active site residues are shown using white surface representation.
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The barrier observed in the trans state also explains why the hydrogen-bonding interaction between Arg
55 and the substrate in one of the four independent normal MD simulations of the trans complex stayed
formed during the entire simulation. Our results suggest that the barrier separating the formed and unformed state of Arg 55 with the substrate in the trans enzyme-substrate complex exists because Arg 55
can equally form long-lasting interactions downward (with the substrate) and upward (with Asn 149),
corresponding to the two observed wells in Fig. 5. Because there is a barrier separating the formed and
the unformed states of the intermolecular interaction between Arg 55 and the trans substrate, these
simulations can get trapped in the formed or unformed well for a long period of time. It is interesting to
see that the configuration of the substrate can directly affect the enzyme dynamics. Fig. 5 also confirms
that the hydrogen-bonding interaction between the guanidinium group of Arg 55 and the carbonyl of
proline in the -Ala-Pro- motif of the substrate can form and break in the trans and cis states and is well
formed as the substrate goes through the transition state.
The hydrogen-bonding interaction between Gln 63 and the substrate is also coupled to the
chemical step, as shown in Fig. 6. The hydrogen bond between Gln 63 and the substrate readily forms
and breaks when the substrate is in the trans or cis states, and stays consistently formed in the enzymesubstrate complex of the transition state (Fig. 6). Gln 63 is completely conserved across the human cyclophilin isoforms (17) and across species (33, 70), and our results suggest that it is primarily important
for stabilizing the transition state of the substrate, along with Arg 55 and Asn 102, two other wellconserved amino acids of CypA (17, 71, 72). The suggested role of Gln 63 in stabilizing the transition
state can be tested by mutagenesis experiments or chemical modification of the side chain in order to
abolish the hydrogen-bonding interaction with the substrate and measurements of the effect on the
catalytic turnover rate.
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Figure 6
Figure 6. Coupling between the intermolecular hydrogen bonding interaction of Gln 63 and the reaction coordinate (ω).
The contour plot (right) is in kcal/mol. The interaction measured is shown on the left with a dashed line. The AlaAla-Pro motif of the substrate is shown with the Ala-Pro shown in the transition state configuration. The remaining
residues of the substrate are shown with a white stick representation. The active site residues are shown using
white surface representation.
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2.5

CypA preferentially binds the substrate in the transition state
We have estimated the binding free energies of the enzyme-substrate complexes with different

configurations of the substrate using the Molecular Mechanics/Poisson-Boltzmann Surface Area approach(57, 58), in order to further understand how CypA speeds up the rate of cis-trans isomerization
(Fig. 7). The relative changes in conformational, translational, and rotational entropies are not included
in these estimates and are assumed to be negligible. The average free energies of binding the substrate
in the trans configuration are ~–13.1 kcal/mol (~–54.8 kJ/mol) in the simulation where Arg 55 does not
interact with the substrate and ~–22.1 kcal/mol (~–92.5 kJ/mol) in the simulation where Arg 55 continuously interacts with the substrate, as shown in Fig. 7A. The average free energies of binding the substrate in the cis and transition state configurations are estimated to be ~–24.1 kcal/mol (~–100.8 kJ/mol)
and ~–31.4 kcal/mol(~–131.4 kJ/mol), respectively. The enzyme binds the transition state better than
the cis and trans states, as was previously shown (13, 73). These results suggest that CypA is designed to
preferentially bind and stabilize the transition state of the substrate. CypA lowers the free-energy barrier by ~10 kcal/mol (~42 kJ/mol), similar to estimates from Figs. 5 and 6 and in line with previous simulations and experiments (13, 34, 67), which is achieved by binding the transition state configuration of the
substrate better than the cis and trans states by thisamount. Also, our results provide a quantitative estimate of the critical role of the interaction of Arg 55 with the substrate in forming a stable enzymesubstrate complex.
A breakdown of the energetic components (Fig. 7, B-E) reveals that the enzyme stabilizes the
transition state configuration using optimized van der Waals and electrostatic interactions. The trans
substrate forms slightly better van der Waals contact with the enzyme than the cis substrate, but the
trans substrate forms the worst electrostatic contact with the enzyme out of the three configurations.
Interestingly, when Arg 55 forms its hydrogen bond with the substrate, the electrostatic contacts significantly improve (Fig. 7C). The cis complex forms significantly better electrostatic contact with the enzyme
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than the trans complex, yet the cis complex forms the weakest van der Waals interactions. This implies
that the cis complex formation is characterized by better hydrogen-bond formation, while the trans
complex formation is characterized by a better grip on the proline ring. The difference in electrostatic
contacts between the ground states is much greater than the difference in nonpolar contacts. This indicates that electrostatic contributions have the biggest impact on complex formation. The importance of
electrostatic contacts in complex formation and catalytic turnover has been previously highlighted(74).
Interestingly, and somewhat expected, the tighter the electrostatic interaction between the enzyme and
the substrate (Fig. 7C), the less favorable the change in the polar free energy of solvation (Fig. 7E). However, the electrostatic and van der Waals interactions overcompensate for the unfavorable change in
the polar solvation free energy. The change in the nonpolar solvation free energy is relatively small (Fig.
7D).
2.6

On the role of Trp 121
Tryptophan 121 forms a hydrogen bond with the substrate, but does not help to carve out the

hydrophobic proline-binding pocket. Therefore, it had not always been considered an active site residue,
but mutating Trp 121 has been shown to adversely affect the catalytic activity of CypA (44, 75, 76). The
amine group of the indole ring can form a hydrogen bond with the backbone carbonyl oxygen of the residue (Phe) after proline of the -Ala-Pro- motif of the substrate (Fig. 8C). The side chain of Trp 121 predominantly populates a single rotameric state, mainly forming hydrophobic contact with the outside of
the proline-binding pocket, and the hydrogen of the indole ring points toward the substrate (Fig. 8, A-C).
Unlike the other residues that form hydrogen-bonds with the substrate, the hydrogen-bonding interaction between Trp 121 and the substrate is well formed in the trans enzyme-substrate complex and
mostly formed in that of the transition state, but completely unformed in the complex of the cis state
(Fig. 8, D and E). The variation in the hydrogen-bonding interaction of Trp 121 is mainly dependent on
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Figure 7
Figure 7. Probability distributions of free energy of CypA binding the substrate in different configurations.
The results are shown for CypA binding the trans (orange and red), transition state (green) and cis (blue) substrate
configurations. Two sets of results are shown for the enzyme-substrate complex with the substrate in the trans
configuration: one in which Arg 55 maintains a formed intermolecular hydrogen bond (orange) and the other
wherein Arg 55 maintains a broken intermolecular hydrogen bond (red). Shown are the total free energy change
upon binding (A) and the individual components of the change in free energy (B to E).
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the configuration of the substrate and not on the dynamics of the residue. A fluorescence study of substrate-free CypA and CypA-CsA complex resulted in a twofold increase in Trp 121 fluorescence upon
binding CsA, suggesting that Trp becomes more localized upon substrate binding (77). Therefore, our
results suggest that Trp 121 may be critical for recognizing the substrate in the trans configuration and
help stabilize the transition state.
Trp 121 is moderately conserved across human cyclophilin isoforms; however, it is well conserved across orthologous CypA species(17, 70, 71). Interestingly, human cyclophilin isoforms without
tryptophan at this position are normally substituted with a histidine or tyrosine, residues that can also
form hydrogen bonds with their side chains(17). A Trp121Phe mutation, which abolishes this hydrogenbonding interaction, causes CypA to bind cyclosporine with much lower affinity, resulting in CsAresistant strains of Saccharomyces cerevisiae(75). The Trp121Ala(44) and Trp121Tyr(76) mutations retain 9% and 19% of wild-type catalytic activity, respectively; to the best of our knowledge, there is no
experimental data for the catalytic activity of the human Trp121His mutant.
2.7

Copyright Notice
This work is published in Biophysical Journal, 2013, 104(1): 216-226.

(http://dx.doi.org/10.1016/j.bpj.2012.11.3815) This work is supported in part by the National Science
Foundation CAREER grant (No. MCB-0953061), the Georgia Cancer Coalition of the Georgia Research
Alliance, and the Molecular Basis of Disease program at Georgia State University. L.C.M. is a Molecular
Basis of Disease fellow. This work was also supported by Georgia State’s IBM System p7 supercomputer,
acquired through a partnership of the Southeastern Universities Research Association and IBM supporting the SURAgrid initiative.

26

Figure 8
Figure 8. Backbone torsional angle distributions of Trp 121 and intermolecular hydrogen-bonding interaction of
Trp 121 with the substrate.
(A) Side chain probability distributions of torsional angle χ1 of Trp 121 and (B) torsional angle χ2 of Trp 121. (C) The
intermolecular hydrogen bonding interaction (in dashed line) between the NH group of Trp 121 and the carbonyl
oxygen of Phe following the Ala-Pro motif. The substrate is shown in the transition state configuration. The rest of
the substrate is shown in white transparent stick representation. The active site residues of CypA are shown as
white surface. (D) The intermolecular distance between the indole NH of Trp 121 and the carbonyl oxygen of Phe
following the Ala-Pro motif of the enzyme-substrate complexes when the substrate is in the trans (red), transition
state (green), and cis (blue) configurations. (E) Probability distribution of the intermolecular hydrogen bonding
interaction between the NH group of Trp 121 and the substrate. The color code is the same as D.
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3

THE COMPLEX ROLE OF ENZYME CONFORMATIONAL DYNAMICS IN CATALYTIC FUNCTION
Enzymes accelerate reaction rates by several orders of magnitude, allowing them to occur at

timescales relevant for cellular functions(10). One of the long-standing issues in biochemistry is how enzymes achieve this remarkable speedup. It is commonly accepted that the most dominating effect arises
from significant reduction in the free energy barrier compared to the corresponding noncatalyzed reaction in solution. It is also well established that this predominant effect is mainly electrostatic in nature
(74, 78), which is more favorable for the transition state than the reactant or the product (10). However,
to what degree and how other factors such as desolvation, steric strain, and enzyme dynamics contribute to catalysis remains disputable. Of particular interest is the role of enzyme dynamics in catalysis that
has stirred considerable debate(32, 70, 79-84) partly because it has not been clearly defined, leading to
a semantic issue. Also, the link between enzyme dynamics and catalysis is difficult to address both experimentally and theoretically. Currently, the implications of enzyme dynamics are from ensemble- and
time-averaged experiments, as the temporal behavior of every atom cannot be observed directly. Although standard MD simulations can provide an atomistic picture of enzyme dynamics, they are still not
amenable to study catalytic reactions that usually occur in milliseconds. Computational approaches that
have investigated the effects of millisecond-timescale enzyme dynamics on the chemical reaction have
been possible only with the use of coarse-grained models (79, 83). NMR relaxation dispersion experiments that can probe microsecond-millisecond timescale motions have detected backbone and sidechain motions in and around the active site that occur on the same millisecond timescale as the chemical step (85). It has been further shown that such slow motions are already present in the free enzyme
(31). Furthermore, loss of conformational fluctuations occurring in milliseconds in the active site of mutant enzyme has been observed with concomitant reduction in activity (84). Single molecule studies on
enzymes have also revealed that catalytic rates can fluctuate over five orders of magnitude – from milliseconds to hundreds of seconds, similar to the range of timescale for conformational fluctuations
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(86).These observations are not surprising given that protein dynamics comprise motions that span multiple timescales and occur in either a more localized or collective manner (87, 88). Nevertheless, protein
dynamics has been suggested to directly contribute to catalytic function and rate enhancement. The
exact nature of this dynamical contribution cannot be understood, unless specific questions regarding
whether dynamical motions of enzymes help in lowering the activation barrier (i.e., barrier effects) or
aid the substrate to surmount the barrier (i.e., prefactor effects) are addressed.
The energy landscape of proteins is characterized by several energy minima that represent conformational substates separated by barriers of varying heights (89, 90). Simultaneous motions of many
degrees of freedom constitute protein dynamics and bring about equilibrium interconversions (88, 91).
We sought to understand the role of enzyme conformational dynamics (ECD) in catalytic functions by
employing a combination of normal MD (nMD) and accelerated MD (aMD) (50) approaches that provide
atomistic detail with extended timescale. We chose to study CypA (Fig. 1A), an extensively studied peptidyl-prolyl cis-trans isomerase, that catalyzes isomerization of the peptide ω-bond preceding proline
residues in proteins. Such system is ideal to study using classical molecular mechanics because no bond
breaking or formation is involved in the catalytic process.
3.1

Probing the influence of CypA dynamics on the chemical step
The uncatalyzed isomerization reaction (RO) is an extremely slow process with an activation bar-

rier of approximately 20 kcal/mol and occurs readily in hundreds of seconds in solution(20, 92). Cyclophilins are known to accelerate prolyl isomerization by 105 – 106 times, reducing the timescale to around
milliseconds(67, 93).It is not feasible to simulate even the catalyzed reaction (RC) with nMD, since it is
currently limited to only hundreds of nanoseconds. Therefore, to probe the effects of ECD in catalysis,
we used several lowered torsional energy barriers around the -Ala-Pro- ω-bond of a well-studied substrate analogue, Ace-Ala-Ala-Pro-Phe-Nme (Fig. 9A). We then took advantage of the linearity of the behavior to extrapolate to the desired barriers. This approach is similar to carrying out experiments in an
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optimum temperature range and extrapolating to a temperature outside that range. The lower barriers
allowed us to track the dwell times in the trans well before going over the barrier with sufficiently good
statistics. Using nMD we investigated the kinetics of prolyl isomerization in the free and the enzymebound substrate with the same value of the AMBER force field parameter V2 (see section 3.6), which is
the main determinant of torsional barrier. We found that the decay of the survival probability function,
S(t), of dwell times for the reference RO in the free substrate unambiguously exhibited single exponential
behavior (Fig. 9B). Progressively slower kinetics resulted as V2was systematically increased from 0 to 11
kcal/mol. Interestingly, for RC, the resulting kinetics exhibited multi-exponential decays (Fig. 9C).
In view of the notion that protein dynamics is not independent of its environment (91), we observed that peptide isomerization dynamics was influenced by environment, whether it be the fluctuations in the solvent or the active site of the environment. From Fig. 9B and D, it became evident that in
terms of timescale, the dynamics of the aqueous environment was relatively uniform with the solvent
motions occurring on a single or a very narrow timescale. In contrast, enzymatic motions were dispersed
over an extensive timescale and were coupled to substrate dynamics. Consequently, the different enzyme dynamic modes became apparent in the isomerization kinetics, yielding multi-exponential behavior (Fig. 1C and E). As the torsional barrier became progressively greater (with the increase in V2), the
distributions of timescales showed the following trend: the relative amplitudes of the faster phases diminished and those of the slower phases showed a gradual increase. These results suggested that, depending on the barrier, and hence characteristic timescale, of the chemical step, the reaction dynamics
got coupled to the slightly faster and slower enzyme motions, resulting in multi-exponential decays.
Overall, the time constant for RO in solution was always larger than the average lifetime of the chemical
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Figure 9
Figure 9. Structure of CypA and the influence of its dynamics on the kinetics of prolyl isomerization in its substrate.
(A) CypA (gray) with its substrate Ace-Ala-Ala-Pro-Phe-Nme in the binding pocket. The binding cavity (VDW surface) is defined by ten residues (nonpolar (white): Phe 60, Met 61, Ala 101, Ala 103, Phe 113, Leu 122, and polar
(cyan): Arg 55, Gln 63, Asn 102, and His 126) that are within 4 Å of the substrate’s Ala-Pro motif. Decay of probability of survival in the trans well as a function of time obtained from nMD simulations of (B) RO and (C) RC with V2 set
to 11.0 (cyan), 9.0 (red), 7.0 (blue), 5.0 (yellow), 4.0 (green), and 0.0 (magenta) kcal/mol. Continuous lines are fits
to single exponential in (B) and multi-exponential functions in (C). (Inset to B) Plots of survival probability functions
on an extended timescale with V2 = 7.0, 9.0 and 11.0 kcal/mol. Parameters from exponential fits of isomerization
kinetics, i.e., the amplitudes and the time constants, τ, are plotted for (D) RO and (E) RC with the same color code as
in (B) and (C).
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step in the enzyme-bound substrate, RC (Table I). It was evident from our results that the chemical step
was coupled to, and would be affected by, the enzyme motions.
3.2

Accelerating CypA Dynamics and its Effects on the Chemical Step
Another question of interest is whether the contribution from ECD can significantly enhance the

rate of the chemical step as compared to that in solution. In answering this question, we subjected only
CypA to increasing levels of aMD with the substrate still simulated with nMD (see section 3.6.3). In order
to confirm that aMD indeed resulted in faster ECD in CypA, we characterized the fluctuations in free
CypA (CO) from independent nMD and aMD (see section 3.6.2 and 3.6.3). Accelerated MD brought about
an increase in not only conformational plasticity; i.e., greater amplitudes of fluctuations as depicted
from the shift of backbone (Fig. 10A and B) and side chain (Fig. B1) order parameters (S2) to lower values, but also conformational heterogeneity (Fig. B2) at the active site of CO. Similar to our results, aMD
has been shown to successfully increase the rate of conformational sampling, thereby characterizing
millisecond-timescale protein/peptide dynamical motions and achieving notable agreement with experimental data (94-98). Our simulations further confirmed recent experimental observations (31, 86) that
ECD in CypA takes place over a broad range of timescales even in the substrate free state (Fig. B1). Accelerating CypA dynamics clearly affected the kinetics of prolyl isomerization in the bound substrate,
resulting in faster decay of the survival probability (Fig. 10C). The decays fitted to multi-exponential
functions with only three phases as opposed to five phases in the nMD of CypA (Fig. 2D). Since the enzyme modes sped up, the relative contribution of the faster phases increased as slower phases became
faster (Fig. 2D). The net result was a gradual speed up in the average lifetimes as the extent of acceleration of CypA motions was increased (Table I).
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Figure 10
Figure 10. Effects of accelerating CypA dynamics on prolyl isomerization in the substrate.
2

Distribution of order parameters (S ) (section 3.6.8) obtained from (A) nMD and (B) aMD of free CypA using the
2
highest level of acceleration. CypA structure is color-coded based on the S values of each backbone N-H bond vector (see color scale). The active site residues are shown with stick representation. Fluctuational motions with the
2
largest amplitudes are indicated by the smallest S (red) while those with the smallest amplitudes are depicted
2
with the largest S (blue). (C) Decay of probability of survival in the trans well as a function of time when V2 = 7
kcal/mol. (D) Parameters of exponential fits in C; i.e., amplitudes and time constants, τ, are plotted with the same
color code as in (C). Shown are the isomerization kinetics in the free substrate (cyan, S) when subjected to nMD
and the enzyme-bound-substrate when CypA was subjected to nMD (blue, ES) as well as aMD at the lowest (orange, A1), intermediate (dark red, A2), and the highest (dark green, A3) level of acceleration. Continuous black
lines are mono- or multi-exponential fits.
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Table 1. Free energy barriers, diffusion and time constants for the uncatalyzed and catalyzed prolyl
isomerization

nMD
nMD
nMD
nMD
nMD
nMD
aMD
aMD I
aMD II
aMD III

V2
(kcal/mol)
0.0
4.0
5.0
7.0
9.0
11.0
28.0
7.0
7.0
7.0

ΔG#
(kcal/mol)
0.81
2.3
3.16
3.93
5.57
7.42
20.0a

RO
<τ>
(ns)
0.05
0.28
0.54
2.48
16.11
61.65
1.22 x 1011b

Deff
(deg2 /s)
18.1 x 1014
18.1 x 1014
18.1 x 1014
18.1 x 1014
18.1 x 1014
18.1 x 1014

ΔG#
(kcal/mol)
0.99
2.31
3.49
10.74a
2.09
2.37
2.7

RC
<τ>
(ns)
0.01
0.07
0.16
0.50
1.35
6.24
2.75 x 105b

Deff
(deg2 /s)
1.37 x 1014
1.37 x 1014
1.37 x 1014
1.37 x 1014
1.37 x 1014
1.37 x 1014
5.443 x 1014
13.362 x 1014
31.229 x 1014

ΔG#s were calculated from potentials of mean force obtained from umbrella sampling except for (a)
where they were obtained after reweighting free energy profiles resulting from aMD. (b) Time constants
extrapolated from linear fits (red and green lines) in figure 11c. AMD levels I, II, and III are the lowest,
intermediate, and the highest extents of acceleration (same as in Fig. 10D) subjected only on CypA. Deff
= 2πkBT.exp(ln(k/ωoωb)ΔG# = 0).
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3.3

Using Kramer’s Rate Theory to Explain the Effects of CypA Dynamics
Although the usage of traditional rate theories to explain enzyme kinetics has been a conten-

tious matter (82, 99, 100), our results could be rationalized within the framework of Kramers’
theory(101, 102) in the high friction regime:

where k is the rate of escape from the trans well with curvature ωo over the free energy barrier ΔG#
with curvature ωb, kB is the Boltzmann constant and T is the temperature. Deff is the effective diffusion
coefficient on a one-dimensional free energy profile and assumed to be independent of the reaction
coordinate. Deff incorporates the effects of the environment, as well as those inherent in proteins, for
example, frictional, dynamical effects and energetic roughness. Frictional effects arise from solvent viscosity and internal friction that impede protein motions. Dynamical effects originate from enzyme with
inhomogenous diffusivity, arising from ECD occurring on a wide continuum of timescales, or an aqueous
medium that offers a more homogeneous environment with essentially single (or very narrowly distributed) diffusion coefficient. The substrate undergoes desolvation while moving into the active site of the
enzyme from aqueous solvent, as a result the energetic roughness may reduce, leading to a less hindered substrate (103). The above Kramers’ relation can be rearranged in the log form, i.e.,

From the plots of

vs. ΔG#,V2 (where rate constants, curvatures, and free energy barrier

heights correspond to various values of V2) with a well-defined slope of 1/kBT, the relative contributions
from the pre-exponential factor and the barrier effects were estimated for RO and RC (Fig. 11). Clearly,
there was a speedup in the isomerization rate in each case of the enzyme-bound substrate as compared
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to the corresponding RO (Fig. 11A). The speedup was the consequence of two opposing effects: Increase
in rate as a result of the reduction of the free energy barrier, for example, 237 times from a barrier reduction of 3.26 kcal/mol in case of V2= 9.0 kcal/mol, which was offset by approximately 2.6 times due to
the modification in the curvatures of the free energy profiles and by approximately 13 times due to the
differences in the Deff in solution and in enzyme-bound substrate, bringing the net rate enhancement to
only about seven times. It can be seen from Fig. 11A that the y-intercept, from which the effective diffusion coefficient can be estimated, is smaller for RC than RO (Table I). Therefore, ECD does not enhance
but rather hinders the rate enhancement. When the dynamics of CypA was accelerated, we clearly noticed an increase in the isomerization rates (Table I). Enzymatic CD does not directly modify the properties of the free energy landscape, as that scenario would violate Boltzmann statistics. However, for each
level of acceleration subjected on CypA, the solvated CypA-substrate complex should be considered a
distinct system associated with its Hamiltonian and characteristic free energy profile. And indeed, the
curvatures and barrier heights were modified (Table I) when ECD was accelerated. As the levels of acceleration were raised, both ΔG# and Deff showed an increase (Fig. 11B) relative to the case in which ECD
was not sped up (i.e., RC). Noticeably, even with the highest level of acceleration, Deff was not significantly faster (i.e., by only approximately 1.7 times) than the one in aqueous solution, given the errors associated with the calculation of quantities from logarithmic scale and MD simulations. Further acceleration
of CypA dynamics could reach a limiting case where the integrity of the active site might be lost as a result of the unfolding of the enzyme brought about by very fast dynamical motions. Our analysis therefore suggested that altering motions associated with ECD made the enzyme’s active site environment
more aqueous-like and directly affected the pre-exponential factor. At the same time, the favorable interactions between CypA and its substrate were possibly perturbed such that the free energy height of
isomerization is increased relative to RC but still remains lower than that for RO.
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Figure 11
Figure 11. Comparison of prolyl isomerization kinetics in the free and the enzyme-bound substrate.Kramers’
#
plots are shown in the form of ln (k/ωoωb) vs ΔG .
(A) nMD data points for RO (open blue circles) and RC(filled blue circles) when V2 = 0, 4, 5, 7, 9, and 11 kcal/mol. (B)
Same plot as in (A). For clarity, only data points from nMD corresponding to V2 = 7.0 kcal/mol are shown. Also plotted are the data points for RC from aMD when the lowest (violet), intermediate (magenta), and the highest (red)
level of acceleration are applied on CypA. All continuous lines are linear fits with slope = 1/k BT. (C) Same plot as in
(A) with linear fits that are extrapolated to higher free energy barriers. Data points for R O (open orange circle) and
RC (filled orange circle) are shown when the lines above the red and below the green lines (with the same slope =
1/kBT) represent illustrative kinetic trends for RC in CypA mutants with faster and slower dynamics, respectively
than the wild-type enzyme. Horizontal and vertical dashed lines with arrows depict reduction in free energy barriers and speedup in isomerization rates (along with sharper curvatures), respectively.
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In an independent aMD study, setting V2to the reoptimized value of 28 kcal/mol (41), we calculated the free energy profiles with the expected actual barriers for RO and RC (see section 3.6.3 and Fig.
B4). We estimated the rate constants (Table I) corresponding to the actual RO and RC from their respective linear fits in Kramers’ plots (Fig. 11C). RC showed a speed up of approximately 4.5 x 105 times over
RO, which was strikingly similar to experimental estimates (67). The above result therefore validated
Kramers’ theory in the analysis of prolyl isomerization kinetics and its catalysis. We would like to note
from Fig. 11C, that in the case of CypA, as one goes to the higher barrier regime, the relative and dominant contribution from the reduction in barrier heights to the rate enhancement will continue to increase while the difference in Deffbetween RO and RCwill remain at approximately 13 times.
Recently, ambient temperature X-ray and relaxation NMR studies on CypA have shown that impediment of motions that help in the interconversion of conformational substates in a mutant enzyme is
accompanied with the reduction in catalytic rate (42). It was therefore concluded that protein dynamic
motions contribute directly to the catalytic power of the enzyme. Such results can now be explained
with Kramers’ theory that allows us to understand the nature of the dynamical contribution. The CypA
mutant with slower dynamics implies that the isomerization reaction would take place on a distinct freeenergy profile with barrier heights and curvatures that are different from the wild-type CypA and with
an effective diffusion coefficient that is perhaps slower than the wild-type enzyme (Fig. 11C). As we
show above, it is equally important to investigate the dynamical effects as well as the free-energy barrier effects of the mutant, which, in most cases, is missing from experimental analyses. The recent studies
linking enzyme dynamics to catalysis have focused on mutants with either slower or total absence of
fluctuations in the active site as compared to the wild-type enzyme (42, 84). It would be interesting to
investigate mutants with faster dynamics (Fig. 11C) and observe whether the catalytic rates are enhanced or not and how they compare with wild-type and nonenzymatic rates.
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3.4

Characterizing ECD in the Free and Bound CypA
We compared the dynamic motions in the active site of CypA in the absence and the presence of

the substrate. Three separate nMD simulations were carried out for the CypA bound complex (Fig. 1A),
when the -Ala-Pro- peptidyl-prolyl ω-bond of the substrate, Ace-Ala-Ala-Pro-Phe-Nme, was allowed to
fluctuate in the trans (Ctrans), transition (CTS), and cis (Ccis) states (see section 3.6.2). No significant differences were observed in either the distribution of backbone dihedral angles (Fig. B5) or amplitudes of
backbone amide bonds in the CO versus boundCypA or between Ctrans, CTS, and Ccis (Fig. B7). However, the
distribution of side-chain dihedrals of the active site residues (Fig. B6) and the fluctuations of selected
side-chain bonds (Fig. B8) showed notable differences in the absence and the presence of the substrate.
Prominently, we found that the side-chain rotamers that were preferred in the bound state are already
sampled in CO and there is simply a redistribution of rotameric population in boundCypA as compared to
CO. Conforming to earlier studies (13, 35), the catalytically important Arg 55, which has been shown to
form stabilizing electrostatic interactions with the substrate in the transition state, exhibited side-chain
motions that were of smaller amplitudes and much more restricted in CTSthan the end states (Figs. B6
and B8). The trajectories of CO,Ctrans, CTS, and Ccis were analyzed using principal component analysis (PCA)
that decomposes the fluctuations in the atomic coordinates into modes ranked according to their relative contribution to the overall protein motion (section 3.6.6). Projection of the trajectories onto the
first three modes that accounted for 90% of the total fluctuations resulted in two-dimensional representation of the multidimensional phase space (Fig. 12A to C). The conformational space sampled by the
active site residues in CO was not only much larger than that in Ctrans, CTS, and Ccis, but also showed considerable overlap with them, indicating that certain fluctuations observed in the enzyme in the presence
of the substrate are already preserved in the free enzyme. CTSoccupied a much more restricted conformational space as compared to Ctrans and Ccis, the side-chain fluctuations in CTS
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Figure 12
Figure 12. Conformational selection and transition state stabilization by CypA.
(A, B, C) Projection of the multidimensional Cartesian space onto the first three principal components. Shown are
the configurations of the binding site residues (see section 3.6.6) resulting from the snapshots of a 300-ns long
trajectory of free CypA (black) and 50-ns long trajectory each of Ctrans (blue), CTS (green), Ccis (red) complexes. (D)
Probability distribution of binding free energies, ΔGbind, of Ctrans, CTS, and Ccis with average values of -20.8, -34.1, and
-24.3 kcal/mol, respectively. The color code is the same as in A-C (Inset) Binding site of CypA (gray VDW) in CTS
where the substrate makes hydrogen bonds (dashed green lines) with active site residues.
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showed decreased amplitudes; i.e., higher S2 values (Fig. B8). As seen in Fig. 12, the smaller ensemble of
CTS consisted of conformations that were a subset of both Ctrans and Ccis ensembles, each of which also
had its own unique set of conformations. Such connectivity between the conformations of the ensembles is important for multiple numbers of possible catalytic pathways. The above results clearly affirmed
the picture of conformational selection (62) wherein the substrate prefers to bind a subset of enzyme
conformations and upon catalysis there is a shift toward the population of enzyme conformations bound
to the product.
3.5

Estimating Binding Free Energies of the CypA-substrate Complexes
We estimated the binding free energies from each snapshot of Ctrans, CTS, and Ccis (Fig. 12D and

section 3.6.7). In support of earlier studies, Fig. 12D revealed that CypA has maximum affinity for the
substrate in the transition state and binds the cis isomer more favorably than the trans isomer (67). The
ability of CypA to bind transition states better than the ground states resulted in transition state stabilization by approximately 10-13 kcal/mol greater than the cis and the trans isomers, respectively (Fig.
12D). The estimates of binding free energy were, however, approximate and did not include contributions from the changes in configurational entropy (section 3.6.7). As seen in Fig. B4 and Table I, we indeed found that the trans and cis free-energy barrier height for the catalyzed isomerization of -Ala-Proω-bond was reduced by approximately 9.3 kcal/mol. Thus, the transition state was stabilized considerably greater as compared to that of the cis or the trans isomers and this alone accounted for a speed up
of approximately 6 x 106 in isomerization rate if the same pre-exponential factor was assumed for RO
and RC. However, we showed Defffor RC to be approximately 13 times smaller than that of RO. Our findings therefore also reinforce the idea of selective binding and transition state stabilization as the major
barrier effect in enhancing the rate of catalysis.
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3.6

Methods
We carried out an extensive characterization of CypA dynamics (including backbone of all resi-

dues and side chains of active site residues) in the absence and presence of its substrate using all-atom
nMD. In order to access long-timescale motions, we further subjected CypA to aMD. We then characterized the isomerization reaction in solution and in the enzyme both kinetically and thermodynamically.
The parameter (V2) in the AMBER force field is the force constant in the dihedral energy function

where n, ω, and γ are the periodicity, dihedral angle, and phase angle, respectively. V2 (for which
n=2and γ = 180˚) predominantly controls the rotational barriers only around the peptidyl-prolyl bonds
with almost isoenergetic cis and trans states. Changing V2modifies the total potential and hence the
free-energy barriers of isomerization. The default or reoptimized (41) value of V2would yield such high
barriers that sufficient number of trans-cis transitions will not be observed in a standard MD trajectory
of even several hundred nanoseconds. Therefore, to make the simulation of kinetics of cis-transisomerization feasible and obtain reasonable statistics, we shifted the isomerization timescale from seconds to nanoseconds by reducing V2to lower values of 11.0, 9.0, 7.0, 5.0, 4.0, and 0 kcal/mol. It should
be noted that V2= 0 kcal/mol does not imply zero torsional barrier. With each value of V2, we performed
individual nMD simulations on the free solvated substrate to model the uncatalyzed reaction in solution
as well as on the CypA-substrate complex to model the catalyzed isomerization in the active site of the
enzyme. In a different set of simulations, the CypA-bound substrate was simulated with nMD with V2 set
to 7.0 kcal/mol while the enzyme was subjected to three increasing levels of acceleration. For each case,
free energy profiles projected onto the ω dihedral were calculated from umbrella sampling. ΔG#, ωo, and
ωb were estimated from such one-dimensional free energy profiles (Fig. B3). The probability of survival
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in the trans well for time t or longer was then calculated from the distribution of dwell times, p(τ), as
follows:

We analyzed our results using the DISCRETE (104, 105) software program that provides nonlinear least
squares solution of multi-exponential decays without any a priori guesses for the number of exponentials or initial parameters. The survivalprobability function, S(t), was fitted to a sum of discrete multiexponential decays; i.e.,

The average rate constant k = 1/<τ> where the average lifetime

.

Aiand τi are amplitudes are time constants, respectively, of phase i in the above function. Using the
MM/PBSA method, we further calculated the binding free energies of Ctrans, CTS, and Ccis to estimate the
contribution of transition state stabilization to the speedup in the isomerization rate.
3.6.1

Preparation of the model structures for MD simulations
To be consistent with previous studies of peptidyl-prolyl isomerase cyclophilin A (CypA) (that

employed monoprotonated CypA at His 92), its x-ray structure (PDB code 1VBT, chain A) was modified
to reflect the protonation state at δ-nitrogen and neutral charge on His 92. The coordinates of the
bound substrate Ala-Ala-Pro-Phe and water molecules were deleted from the PDB file and the missing
first residue methionine was added using the xleap program. After neutralizing the positive charges on
the protein by the addition of equal number of counterions, CypA was solvated in a truncated periodic
octahedral box (having approximate dimensions of 75 x 75 x 75 Å3) with solvent placed at a spacing distance of up to 10 Å away from the solute unit and was filled with 4996 TIP3P water molecules. An initial
minimization of 1,000 steps with the steepest descent algorithm was carried out in which CypA was held
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with a harmonic restraining force constant (k) of 100 kcal/mol▪Å2 while the solvent was allowed to relax.
Subsequent to this, two MD runs were performed: the first run for 100 ps with a k of 100 kcal/mol▪Å2
followed by the second one for 200 ps in which k was reduced to 20 kcal/mol▪Å2. Finally, the system of
solvated CypA was equilibrated for 200 ps without any restraints on the protein. These steps brought
the density and temperature of the system to approximately 1 g/mL and 300 K, respectively.
To make structures for substrate-bound CypA, we begin with the crystal structure of CypA in
complex with the peptide HAGPIA from HIV-1 capsid protein (PDB code 1AWR, chain A). Using xleap we
then modified the substrate in the complex to a blocked tetrapeptide Ace-Ala-Ala-Pro-Phe-Nme, one of
the most specific and widely studied substrates of CypA. Since the ω dihedral between Ala-Pro moiety is
in the default trans configuration, we used the resulting structure for CypA bound to the substrate in the
trans state (Ctrans). We solvated this complex in a truncated periodic octahedral box filled with 5552
TIP3P water molecules that were placed up to 10 Å away from the solute unit. We then subjected the
system to the four step equilibration as was done for the free enzyme (see above). Since the ω dihedral
between Ala-Pro moiety is in the default trans configuration (i.e., around +180˚), we used the equilibrated structure as the starting configuration for our standard MD simulations on CypA bound to the substrate in the trans state (Ctrans). To model the complex of CypA and the substrate in the transition state
(CTS), the ω dihedral was gradually changed to 90˚ with restraints during an additional equilibration. During the equilibration and production runs the Ala-Pro ω dihedral was restrained in the transition state
configuration using a flat-welled parabola with its flat region defined by 90˚+ 5˚ and linear region by
90˚+ 10˚ with a force constant of 1,000 kcal/mol▪rad2. Starting with the equilibrated structure of CTSwe
carried out an additional short equilibration in the absence of any restraints that allowed the ω dihedral
to achieve the cis configuration (i.e., around 0˚). We used this resulting structure as the initial model for
simulations on CypA bound to the cis isomer of the substrate (Ccis).
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The starting structure of the free substrate Ace-Ala-Ala-Pro-Phe-Nme was generated using the
xleap program. The peptide was then solvated in a cubic periodic box with each side being 35 Å and
filled with 1183 TIP3P water molecules. The water molecules were placed up to 10 Å away from the peptide and the system was subjected to minimization and equilibration as described in (41). The ω-bond
between the Ala-Pro moiety was generated in the trans configuration by default and remained in that
configuration throughout the equilibration phase.
3.6.2

Normal molecular dynamics (nMD) simulations
We performed MD simulations with the AMBER 10(37) suite of programs with the modified ver-

sion of the parm99 (39) force field. We used the reoptimized parameter(41) for the torsional force constant, i.e., V2 = 28 kcal/mol, that controls the potential energy barrier to rotation about the ω-bond. All
input files were generated using the xleap program and the crystal structures from the protein databank
(PDB). The equilibration and production runs for each study were carried out at the NPT (number of atoms, pressure, and temperature are kept constant) ensemble with a constant pressure of 1 bar and a
temperature of 300 K. Temperature and pressure regulation was achieved, respectively, using a Langevin thermostat with collision frequency of 1 ps-1 and isotropic position scaling with a coupling constant
of 1 ps for coupling to external pressure bath. Bonds involving hydrogen atoms were constrained using
the SHAKE (46) algorithm with a tolerance of 0.0001. Particle mesh Ewald (49) method was used to
evaluate long-range interactions whereas short-range non-bonded interactions were calculated with a
cutoff of 9 Å. An integration time step of 2 fs was used to numerically solve Newton’s equations of motion. Data was saved every 500 steps, i.e. every 1 ps. The production runs were performed in sets of 10
ns, each time restarting the simulation with a unique random number seed.
While free CypA was subjected to nMD for 300 ns, for each complex of CypA i.e. Ctrans, CTS, and
Ccis production runs of 50 ns were performed. In each case, the first 10ns of data were assigned to an
additional equilibration and hence was discarded for any further analysis. Since the activation barriers to
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cis-trans isomerization are very high; i.e., approximately 20 kcal/mol, no transitions from trans to cis or
vice versa were observed in the nMD simulations of the CypA-substrate complexes. Also, throughout the
length of the simulations the CypA-substrate complexes were found to be intact; i.e., the substrate remained in the binding pocket of CypA. For CTS, the ω dihedral was restrained around 90˚ during the production runs. In addition to MD simulations on free CypA and CypA-substrate complexes we performed
nMD on the free substrate for 50 ns.
3.6.3

Accelerated molecular dynamics (aMD) simulations
aMD simulations were carried out with the pmemd module that was modified in-house for the

implementation of the aMD formulation (50). A continuous and nonnegative bias potential prescribed
earlier by Hamelberg et al. (50), which has the form

was added to the original potential V(r) only when E – V(r) > 0; i.e., to the non-transition state regions.
aMD was employed for four different cases: (1) free CypA, (2) substrate-bound CypA for kinetic studies,
(3) free substrate for equilibrium studies, and (4) substrate bound to CypA for equilibrium studies. For
cases 1 and 2 that were aimed at speeding up the conformational dynamics of CypA, three different and
increasing levels of acceleration were elicited by setting α to 64 kcal/mol and varying E as 700, 1,100,
and 1,500 kcal/mol above the average total dihedral energy of approximately 1,612 kcal/mol. For each
level of acceleration, the production phase runs were carried out for 110 ns. The bias potential was applied to all the torsions of the enzyme in cases 1 and 2. However, in case 2, only CypA was subjected to
aMD, the bound substrate was simulated with nMD. For cases 3 and 4, aMD was used to increase the
conformational sampling rate to observe several cis-trans transitions and obtain free energy profiles
(Fig. B4) after applying the reweighting procedure described in (41). aMD was carried out for the free
substrate with E = 107 and α = 10 kcal/mol, which was run for 780 ns, and with E = 102 and α = 5
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kcal/mol run for 410 ns, giving a total simulation time of 1.19 μs. For these simulations, V2 was set to the
reoptimized value of 28 kcal/mol. The VMD (106) program was used to visualize molecules and prepare
Figs. 9A and 10A and B.
3.6.4

Kinetic studies of prolyl isomerization in free and enzyme-bound substrate
The torsional barriers were reduced to 11.0, 9.0, 7.0, 5.0, 4.0, and 0 kcal/mol. For each barrier,

we initiated several thousand trajectories starting with the substrate in the trans well and terminated
each of them once the substrate escaped from the trans well and reached the transition state (i.e., +90˚)
in the anticlockwise direction or when the substrate diffused out of the active site. Unlike the free substrate where bidirectional transitions of the trans basin are equally probable, the barrier for the trans to
cis transitions is much lower in the anticlockwise direction in the CypA-bound substrate. Therefore, to
compare catalyzed and uncatalyzed reaction on equal footing, the transitions in the clockwise direction
were discarded in the bound and free substrates.
3.6.5

Umbrella sampling for obtaining potentials of mean force (PMF)
In order to generate the PMFs along the ω dihedral, the cis-trans isomerization in the free and

enzyme-bound substrate was simulated using the combination of nMD and umbrella sampling (107).
The following set of procedures was repeated for the free substrate having different torsional barriers
(i.e., V2) of 9.0, 7.0, 5.0, 4.0, and 0.0 kcal/mol and for the enzyme-bound substrate with V2= 9.0 kcal/mol
(Fig. B3). Umbrella sampling simulations were run in 11 separate windows, each having the same harmonic potential restraint (i.e., force constant of 32.83 kcal/mol▪rad2 or 0.02 kcal/mol▪deg2) and ran for 1
ns. The windows were placed every 10˚ along the ω dihedral starting from 80˚ and ending at 180˚. To
ensure that the biasing potential is harmonic everywhere the width of each window was maintained at
360˚ (i.e., +180˚ from the position of ω where each window is placed). In addition, the distance between
the amide proton of Phe 113 and Cαof the substrate’s Pro was restrained at 11 + 0.5 Å by applying a

47
harmonic force constant of 1,000 kcal/mol▪Å2 to ensure that the substrate remained in the active site of
CypA through the simulations. Data from each window was unbiased and combined using the rapid and
memory efficient implementation (108) of the Weighted Histogram Analysis Method (WHAM) (109) by
Alan Grossfield. Each PMF was finally calculated using 100 bins and a convergence tolerance of 10-6
kcal/mol in the WHAM program.
3.6.6

Decomposition of the hyper-dimensional conformational space of CypA active site to a few
relevant and vital dimensions
Using the ptraj module of AMBER we carried out principal component analysis (PCA) (110) on

the snapshots resulting from the three simulations on Ctrans, Ccis, and CTS. The covariance matrix of the
Cartesian atomic coordinates of all the atoms of the seventeen binding site residues of CypA was calculated. These residues (i.e., Arg55, Phe60, Met61, Gln63, Gly74, Gly75, Glu81, Ala101, Asn102, Ala103,
Thr107, Gly109, Ser110, Gln111, Phe113, Leu122, His126) define the binding site with two cavities, one
acting as the active site and the other important possibly for interaction with protein substrate. The diagonalization of the covariance matrix resulted in a set of eigenvectors and the corresponding eigenvalues. The first, second, and third largest eigenvalues contributed for more than 90% of all the atomic fluctuations. Projections of the combined trajectories of three individual simulations on these three dominant modes are plotted in Fig. 12A, B, and C.
3.6.7

Estimation of the binding free energies of the enzyme with substrate in trans, transition state,
and cis configurations
We used the Molecular Mechanics/Poisson-Boltzmann Surface Area [MM/PBSA (57, 58)] meth-

od to calculate the binding free energies (ΔGbind) of Ctrans, Ccis and CTS. ΔGbind = ΔGsolv + ΔH - TΔS where
ΔHis the sum of molecular mechanics energy (i.e., contribution from interaction energies: electrostatic,
van der Waals, bond, angle and dihedrals) and ΔGsolv is the solvation free energy that has polar and non-

48
polar components. The polar component, which accounts for the interactions with the solvent, was estimated with PB implicit solvation, whereas the nonpolar contribution was obtained from solvent accessible surface area. The change in conformational entropy, ΔS was not estimated in this study. For every
snapshot of the three trajectories (i.e., free enzyme, free substrate and each enzyme-substrate complex,
i.e., either Ctrans, Ccis and CTS) each energy component in the ΔHterm for the free CypA and the free substrate was subtracted from the respective component of the CypA-substrate complex. We therefore obtained a ΔGbindvalue for each snapshot. The probability distributions of ΔGbindare shown in Fig. 12D. Further, we also estimated the change in translational and rotational entropies and found them to cancel
out between the bound and the free enzyme (data not shown). However, as evident from Fig. 12A, B, C
the change in conformational entropy will be different forCTS in comparison to other bound states and
we expect to get more realistic estimates of ΔGbindupon inclusion of the TΔS term in the future.
3.6.8

Calculation of the order parameters (S2)
S2 values for backbone N-H or side-chain bond vectors were obtained from the plateau region of

the autocorrelation functions calculated by the ptraj module of AMBER by applying second order Legendre polynomials. Order parameters were not calculated for residues that did not have amide bonds; i.e.,
the first residue and prolines. For prolines, we assigned an arbitrary value of 1.
3.7

Characterization of CypA dynamics
We examined the distributions of side-chain dihedrals of active site residues excluding alanines

and included Ser99 that is located much farther from the active site. We considered Ser99 despite the
fact that it is away from the active site because it has been shown (85) to exhibit changes in NMR chemical shifts between two CypA conformers that are comparable to those of active site residues. Interconversions between conformational substates that require protein dynamics on timescales slower than
microseconds will not be observed in finite-length (i.e. 0.3 μs) normal MD. Therefore we carried out ac-
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celerated MD to increase the sampling rate as well as the conformational space sampled by the free enzyme. Indeed, changes were observed in the conformational distributions of the side-chain dihedrals of
the active site residues when we compared the results from normal MD to those from accelerated MD
at different levels of acceleration (Fig. B2). The side-chain dihedrals for Phe60, Ser99, Phe113, Leu122,
His126 that essentially showed a single peak in normal MD was observed to populate more than one
rotamer in accelerated MD. With accelerated MD Met61 also exhibited a third peak in addition to two
existing rotamers. For the remaining residues, the number of rotamers, as observed in normal MD, remained constant and showed only a redistribution of population in accelerated MD. In these residues
the rotameric transitions (time plots not shown) were also more rapid, suggesting that dynamics slower
than the microsecond timescale was captured in accelerated MD. For ease of comparison between our
study and recent crystallographic studies by Alber and coworkers (42) we rescaled the range of sidechain values obtained from MD simulations, i.e. [-180˚ to +180˚] to [0˚ to 360˚] by adding 360˚ to angles
less than 0˚. The positions of the major and minor peaks also agreed well with the X-ray data shown in
Fig. 9A of (42), indicating that MD simulations sampled true conformations. These results clearly showed
the plasticity and conformational heterogeneity present in the active site of CypA even in the absence of
substrate. Performing increasing levels of accelerated MD not only extended the sampling range but
also allowed us to identify the potentially slow timescale motions.
We found no significant difference in the backbone dihedral space sampled by the active site
residues in the free and the substrate-bound CypA (Fig. B5). Comparison of the distributions of sidechain dihedrals in the free and substrate-bound CypA (Fig. B6) clearly indicated that the side-chain rotamers preferred in the bound CypA were already sampled in the free enzyme, conforming to experimental observations(31). There was simply a shift in the rotameric population going from the free to the
bound CypA or from one bound state to another. As compared to Ctrans or Ccis, the side-chain dihedrals in
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CTS essentially populated a single rotamer, indicating reduced conformational heterogeneity. These results affirmed a conformational selection mechanism for CypA.
From Fig. B7, we noticed that as compared to the free CypA, the amplitudes of backbone fluctuations did not seem to vary significantly for the bound CypA. The amplitudes of side-chain bond fluctuations, in general, seemed to reduce in the bound CypA as compared to the free CypA (Fig. B8). Also, certain side-chain bonds became more rigid in CTS as compared to Ctrans and Ccis. Interestingly, the catalytically important residue Asn 102, which is known to make interactions with the substrate that stabilize
the transition state, exhibited the opposite trend; i.e., the amplitude of its side-chain motions was highest in CTS.
3.8
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4

CYCLOPHILIN A INHIBITION: TARGETING TRANSITION STATE BOUND ENZYME CONFORMATIONS
FOR STRUCTURE BASED DRUG DESIGN
Cyclophilin A (CypA) is a member of the immunophilin family of enzymes (111) that play critical

roles in various biological processes, such as enhancing the rate of protein folding (or unfolding) via its
peptidyl-prolyl isomerase (PPIase) activity (16, 112).CypA is an important drug target for cyclosporine A
(CsA), an immunosuppressive inhibitory drug that is widely used to prevent organ rejection after transplant operation (113). CypA performs an essential function during the maturation of the HIV-1 virus,
catalyzing cis-trans isomerization of a -Gly-Pro- motif on an exposed loop of the HIV-1 capsid monomer
in order to facilitate viral replication (114, 115). Recent studies show that CypA is overexpressed in many
cancer cells, such as human pancreatic cancer cells, oral squamous cancer cells, endometrial carcinoma,
and nonsmall cell lung cancer cells (116-119). CypA also binds to the nucleocapsid protein of SARS coronavirus, which causes infection, and CypA induces neuroprotective or neurotrophic effects when present at high levels in the brain (120-122). Due to the involvement of CypA in the regulation of numerous
biological processes and related diseases, CypA has been identified as a potential drug target. Therefore,
significant efforts have been put into discovering potent CypA inhibitors and discriminating between
different isoforms of cyclophilin (123-125). Well known inhibitors of CypA, such as CsA and sanglifehrin
A, were derived mainly from natural products and peptide analogues (111, 126-128) and tend to have
low solubility in water and serious side effects (129).
Along with in vitro drug synthesis, computational docking and virtual screening methods have
become an integral part of structure-based drug design and play important roles in developing new drug
candidates (130). In traditional docking and virtual screening methods, a single or few X-ray crystal
structures (or homologous structures) are used along with a fully flexible ligand (131-134). In recent
years, the flexibility of the receptor’s active site is taken into consideration by allowing for small movements in the protein backbone and significant changes in the rotameric states of the amino acid side
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chains (135-138).Furthermore, large-scale conformational rearrangements of the receptor can be
achieved a priori using one of many conformational sampling techniques, such as molecular dynamics
(MD) simulation (139). These approaches, which are normally referred to as ensemble docking or relaxed complex methods (140-142), use a diverse ensemble of conformations of the receptor and provide
a probability distribution of binding free energies or scores for a particular ligand. The diversity of the
receptor conformations will depend on the extent of sampling and whether the relevant conformations
are readily accessible by the free receptor. Nonetheless, relaxed complex approaches have been shown
to do better in identifying potent inhibitors than approaches that use a single or few conformations of Xray crystal structures (143-147). Additionally, it has been suggested that the performance or predictive
power of virtual screening can be improved by using an ensemble of receptor conformations that were
generated in complex with bound ligands or substrates (148). One could therefore argue that the ligand
or substrate induces a subset of pertinent conformations in the binding site that are poorly or never
sampled in the free receptor. Therefore, obtaining and identifying the relevant ensemble of enzyme
conformations for rational drug design is critical to the development of potent inhibitors. However, because of the hyper-dimensional landscape of biomolecules, the conformational sampling of the free receptor is not always exhaustive.
In an enzyme,the ensemble of accessible conformations could depend on the conformational
states of the natural substrate. In CypA, for example, the substrate can exist in the cis, trans, or transition state configurations during catalytic turnover and the X-ray crystal structures may not be representative of the different ensembles of enzyme conformations that bind the substrate in the different
configurations. Also, unless the conformational sampling of the substrate-free receptor, using MD or
some other methods, is exhaustive, there is the possibility that relevant ensembles of conformations in
the catalytic pathway that may prove useful for inhibitor design may not be adequately sampled. Therefore, there is a need to reliably and efficiently access these conformations, especially if the active site of
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the enzyme significantly rearranges during catalytic turnover.Is it necessary to consider all of the possible conformations of the free enzyme or is there a subset of conformations that is the most relevant for
designing potent inhibitors? For example, transition state analogues (mimics) have always been designed and used as potent inhibitors (149). The extent to which an enzyme stabilizes the transition state
relative to reactants and products determines the efficiency of the enzyme. Therefore, a small molecule
that can bind to the enzyme’s transition state ensemble of conformations can reduce the overall activity
of the enzyme. Is the ensemble of enzyme conformations that recognizes the transition state the most
relevant in designing potent inhibitors?
To answer these questions, we have used human CypA as a case study and carried out all-atom
molecular dynamics simulations on the substrate-free enzyme, the enzyme-substrate (Ace-Ala-Ala-ProPhe-Nme) complexes when the peptide ω-bond angle of the -Ala-Pro- motif is in the cis (0˚), transition
state (90˚), and trans (+180˚) configurations, and six enzyme-inhibitor complexes. The transition state
and the other configurations of the substrate of CypA are reliably defined, since there is no bond formation or breakage during the catalytic process. Six previously reported small active nonpeptidomimetic
inhibitors (123, 150-153) (Figure 13) are used in this study. The activities (IC50) of these inhibitors are in
the nanomolar to micromolar range.
We have analyzed the trajectories of ten molecular dynamics simulations in order to probe the
motions of ensembles of conformations of the active site of CypA in its substrate-free, substrate bound,
and inhibitor-bound states. The substrate-free simulation of CypA was carried out for 340 ns, and three
substrate-bound simulations of CypA were carried out, each for 50 ns, with the peptide ω-bond angle of
the -Ala-Pro- motif of the Ace-Ala-Ala-Pro-Phe-Nme substrate analogue in the trans, transition state, and
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Figure 13
Figure 13. Active site of cyclophilin and known inhibitors.
(A) Active site of CypA consisting of a polar pocket (blue surface) and a nonpolar pocket (white surface), connected
by a channel that is partially polar. (B) Chemical structures of inhibitors considered in the study (A(150), B(153), C,
D(152), E(123), F(151)) with their IC50 values in parentheses. The Ki, instead of the IC50, is reported for compound E.
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cis configurations. Six inhibitor-bound CypA complexes were also simulated for 30 ns each, using the six
inhibitors listed in Figure 13.
4.1

Conformational Changes in the Active Site of Cyclophilin A
The active site of CypA comprises a hydrophobic proline binding pocket and a polar pocket that

are connected by a narrow partially polar channel, as shown in Figure 13. We have characterized the
dynamical motions of the active site residues of CypA in the absence and presence of the peptide substrate analogue. The trajectories of the bound and unbound simulations were analyzed using principal
component analysis (PCA) to determine the top principal modes (eigenvectors) that represent the dominant motions of the active site. Projections of the top three slowest modes that represent the majority
of the total fluctuation of the active site residues are shown in Figure 14. The conformations of the active site residues of the substrate-free enzyme contain the conformations that can bind the trans, cis,
and transition state configurations of the substrate. The conformations of the bound enzyme are intrinsic to and are present in the free enzyme. Each data point shown in Figure 14 represents a conformation
of the active site in the free, trans, transition state, and cis ensembles.
The enzyme conformations that bind the substrate in the trans, cis, and transition state configurations of the substrate are distinguishable (Figure 14), with some overlapping regions. These results
suggest that the active site of the free enzyme can easily change its shape to accommodate the different
states of the substrate during catalytic turnover, favoring mainly conformational selection (62). It appears that the binding site of the enzyme has evolved to be inherently plastic with a notable decrease in
the fluctuation of the transition state ensemble. The considerable loss in plasticity is attributed to wellformed intermolecular interactions, both polar and nonpolar between the enzyme and the substrate at
the transition state. We previously estimated the binding free energies of each ensemble corresponding
to the complex of enzyme with the substrate in the different configurations using the MM/PBSA (Mo
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Figure 14
Figure 14. Top three principal component of the active site residues of the different CypA ensembles: (free)
black, (cis) red, (transition state) green, and (trans) blue.
The active site residues are Arg 55, Phe 60, Met 61, Gln 63, Gly 74, Gly 75, Glu 81, Lys 82, Ala 101, Asn 102, Ala 103,
Thr 107, Gly 109, Ser 110, Gln 111, Phe 113, Leu 122, and His 126. The substrate analogue (Ace-Ala-Ala-Pro-PheNme) is in the transition state configuration.
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lecular Mechanics/Poisson-Boltzmann Surface Area) approach (57). We found that the transition state of
the substrate binds better than the cis, and the cis binds better than trans configuration (73). These results indicate that the enzyme is preorganized to bind the transition state configuration of the substrate
better than the cis and trans configurations, as was previously shown(13).
4.2

Potent inhibitors are recognized by functionally relevant active site conformations of CypA
CypA-inhibitor complexes of six previously reported inhibitors (A – F in Figure 13) were used to

study the conformational preference of the active site upon ligand binding. The binding modes of the
inhibitors in the active site of CypA are shown in Figure 15. Crystal structures are available for inhibitors
A and B. The binding of C – F were obtained by docking the inhibitors into the active site of an ensemble
of conformations of CypA using AutoDock Vina (154) and identifying the binding mode with the most
probable binding affinity. Compounds A and B were redocked into the active site of the respective crystal structures and an ensemble of conformations of CypA that was generated using molecular dynamics.
The resulting binding modes were similar to those in the crystal structures (see Figure C1). The binding
site of CypA consists of the proline binding nonpolar cavity and an adjacent polar cavity, separated by a
partially polar channel, as shown in Figure 13. In all cases, nonpolar groups (phenyl or fused-rings) occupy the nonpolar pocket, whereas polar groups occupy the channel and the polar pocket. These structures were used as starting structures for 30 ns of molecular dynamics simulations for each compound.
The last 20 ns were used for the analysis. The initial positions of the compounds were not significantly
altered during the simulations, except for compound C.
Principal component analysis was carried out on all atoms of the active site residues of CypA to
identify the overall patterns of motions upon binding the inhibitors. Projection of the top three eigenvectors accounts for more than 75% of all motions in the free enzyme. The top three principal components of compounds A – F are shown in Figure 16. Figure 16 shows that the presence of compounds (A –
F) in the active site dramatically changes the internal motions of CypA. For all of the compounds (A – F),
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Figure 15
Figure 15. Binding modes of the different inhibitors of CypA.
The binding modes of compounds A and B are taken from the crystal structures with PDB ID 1CWA and 3RDD, respectively. The most probable binding modes for the compounds C-F were obtained using AutoDock Vina.
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Figure 16
Figure 16. Top three principal components of the motions of the active site residues of the different CypA ensembles: (free) black, (cis) red, (transition state) green, (trans) blue, (A) cyan, (B) magenta, (C) gray, (D) violet, (E)
brown, and (F) yellow.
The active site residues are Arg 55, Phe 60, Met 61, Gln 63, Gly 74, Gly 75, Glu 81, Lys 82, Ala 101, Asn 102, Ala 103,
Thr 107, Gly 109, Ser 110, Gln 111, Phe 113, Leu 122, and His 126.
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the principal modes overlap considerably with those of the transition state and cis configurations. Our
studies suggest that the enzyme conformations of the cis and transition state complexes are the most
selective for inhibitor binding and can, therefore, be the most suitable for designing novel drug candidates. This could be a general phenomenon, since it has been known for a long time that transition state
mimics tend to always lead to better inhibitors. Our studies provide a molecular level description of this
phenomenon. The active site residues adopt conformations that bind the substrate in the different
bound states and are the most relevant to the activity of the enzyme. Lack of ergodicity in the sampling
of the free enzyme could lead to limitations in sampling conformations that may or may not be relevant
to the catalytic function of the enzyme. One could directly use the transition state or cis ensemble of
enzyme conformations in structure-based drug design. However, the challenge in using the transition
state ensemble of the enzyme in rational drug design is that the transition state of the reaction is not
always well-defined a priori. In the case of CypA, which does not involve bond breaking or formation
during catalysis, the transition state is easily identifiable and modeled using classical molecular mechanics.
4.3

Conformational dynamics of the nonpolar and polar cavities and implications for drug design
The proline hydrophobic binding cavity samples a broader range of configurations in the free

enzyme than in the trans, cis, and transition state complexes (Figure 17A). The hydrophobic cavity of
the transition state ensemble is more localized than the cis and trans ensembles. The highly localized
hydrophobic pocket of the proline-binding pocket is partly responsible for the tighter binding of the
transition state configuration of the substrate by CypA. All of the inhibitors also occupy the localized hydrophobic binding pocket of CypA. The conformations of the hydrophobic cavity of the enzyme of the
inhibitor-bound complexes cluster around the same area along the top three principal modes (Figure
17B) and are similar to that of the cis, trans, and transition state enzyme ensembles.
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Figure 17
Figure 17. Top three principal components of only the hydrophobic pocket residues of the CypA ensembles of (A)
(substrate-free) black, (cis) red, (transition state) green, and (trans) blue and (B) inhibitor-bound CypA: (A) cyan,
(B) magenta, (C) gray, (D) violet, (E) brown, and (F) yellow.
The hydrophobic pocket was defined using the following residues: Arg 55, Phe 60, Met 61, Gln 63, Ala 101, Asn
102, Gln 111, Phe 113, Leu 122, and His 126.
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Similarly, the hydrophilic cavity of the bound complexes of the different states of the substrate and inhibitors also samples a smaller region of conformational space than that of the substrate-free enzyme
(Figure 18). The one exception is the enzyme ensemble of the substrate in the trans configuration, which
samples as much space as the free enzyme. It is worth noting that the substrate in the trans configuration has the weakest binding affinity to the enzyme than the cis and transition state configurations. The
conformations of the hydrophilic cavity of the inhibitors are similar to those of the transition state and
the cis configuration of the substrate (Figure 18B). It is interesting to note that the hydrophilic cavity is
not occupied by the peptide substrate analogue in the different states and is occupied by only some of
the inhibitors. Instead, there are localized water molecules in the hydrophilic cavity.
Molecular dynamics simulations reveal that the inhibitors occupy mainly the proline binding hydrophobic pocket and the polar channel. In the crystal structure, as well as in the simulation, compound
B partially occupies the hydrophilic pocket with the amino-benzyl group, whereas water molecules fill
the polar pocket in the other complexes (Figure 19). Figure 19 shows the hydration density maps of
CypA in complex with compounds A (CsA) and B. CsA does not occupy the hydrophilic pocket, and this
pocket is filled with localized water molecules. Compound B partially occupies the hydrophilic pocket
and displaces some of the localized water molecules in the hydrophilic pocket. Mikol et al. (150) reported that a CsA (compound A) derivative that occupies the polar pocket by displacing a structural water
molecule has significantly decreased potency as compared to CsA. In this later case, the unfavorable
desolvation free energy and conformational destabilization energy of the modified CsA contributed to
diminished binding affinity. Several studies have investigated the importance of interfacial water molecules in protein-ligand complexes (155-158). In some cases, careful redesigning of a ligand to displace
localized water could lead to better affinity. For example, HIV protease inhibitors that were designed to
displace and mimic the interactions of the bound water molecules were found to bind more strongly to
the protein and improved the biological activity. A possible gain in entropy upon the water release and
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Figure 18
Figure 18. Top three principal components of only the hydrophilic pocket residues of the CypA ensembles of (A)
(substrate-free) black, (cis) red, (transition state) green, and (trans) blue and (B) inhibitor-bound CypA: (A) cyan,
(B) magenta, (C) gray, (D) violet, (E) brown, and (F) yellow.
The hydrophilic pocket was defined using the following residues: Gly 74, Gly 75, Glu 81, Lys 82, Ala 101, Asn 102,
Ala 103, Thr 107, Gly 109, Ser 110, and Gln 111.
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Figure 19
Figure 19. Hydration density around inhibitor-bound complexes of CypA for inhibitors (A) A and (B) B.
Active site residues are shown in surface with hydrophilic and hydrophobic cavities colored in blue and white, respectively. The inhibitors are in purple transparent ball and stick model. The green colored mesh represents the
hydration density approximately five times that of bulk water.
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the redesign of the flexible inhibitor into a conformationally restricted one that matches the shape of
the active site contributed to the improved affinity (159). Similarly, the scytalone dehydratase inhibitors,
such as salicylamide analogue inhibitors, that displace one of the crystallographic water molecules have
higher inhibitory activity (160). Many examples have been reported in the literature wherein ligands are
designed to form direct hydrogen bonds or displace water molecules in order to achieve higher binding
affinity (157, 161). Therefore, it appears that the biological activity of drugs could be improved by minimizing the loss of the conformational entropy of the compounds that can form strong direct hydrogen
bonding interactions with the receptor (162).The gain in binding affinity upon displacing localized water
molecules can potentially be achieved if the displacing group is preorganized to bind in the cavity with
little or no loss in entropy and the interaction energies and gain in entropy of releasing the localized water molecules overcompensate for the loss in conformational entropy.
Our results suggest that a compound with a bulky nonpolar group, similar in size to the nonpolar
pocket, and a polar group, similar in size to the polar cavity, that are on opposite sides of a polar linker
with the appropriate length are necessary to achieve high selectivity for CypA. Furthermore, minimizing
the number of rotatable bonds in order to reduce the loss in conformational entropy upon binding could
enhance the affinity. More detailedfree energy calculations (124) can be carried out on lead compounds
to further optimize binding and selectivity in silico.
4.4

Methods
A 1.58 Å resolution crystal structure with PDB ID 1AWR (25) was used to carry out the simula-

tions of the substrate-free and substrate-bound CypA. All simulations are carried out using AMBER 10
suite of programs (163) in explicit TIP3P (38) water model in a periodic octahedron box, using the modified version of the all-atom Cornell et al. (40) force field and the reoptimized dihedral parameters for the
peptide ω-bond (41). The systems were brought to electrostatic neutrality by adding chloride ions. A
total of ten MD simulations were carried out: a 340 ns simulation of substrate-free CypA, three simula-
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tions of CypA-substrate complexes, each ran for 50 ns, with the peptide ω-bond angle of the -Ala-Promotif of a well-studied substrate analogue (Ace-Ala-Ala-Pro-Phe-Nme) in the trans, cis, or transition
state configurations, and six simulations of CypA-inhibitor complexes (Figure 13), each ran for 30 ns. The
substrate analogue was derived from the original substrate, HAGPIA, in the PDB file by keeping the
backbone and common side chain atoms and allowing xleap to add the missing atoms. The crystal structure contains the substrate in the trans configuration. The substrate was kept in the transition state configurations by restraining the peptide ω-bond angle using a flat-bottom well potential at ~90˚ with a
force constant of 1000 kcal/(mol rad2). The simulations of the CypA-substrate complexes when the substrate was in cis and trans configurations were carried out with no restraints, since the two ground state
configurations are separated by a high barrier. First, the systems are minimized to achieve the lowestenergy conformations. The systems were equilibrated using MD for 200 ps with a 50 kcal/(mol Å2) harmonic constraint applied to all of CypA, bringing the temperature up to 300 K. A second equilibration
was carried out at 300 K for 200 ps with a 25 kcal/(mol Å2) harmonic constraint applied to all of the atoms of CypA. The final equilibration was carried out for 200 ps without any harmonic constraints. During
the simulations, an integration time step of 0.002 ps was used to solve the Newton’s equation of motion. The Particle Mesh Ewald method (49) was used to evaluate long-range electrostatic interactions,
and a cutoff of 9.0 Å was used for non-bonded interactions. The SHAKE algorithm (46) was used to restrain all bonds involving hydrogen atoms. The simulations were carried out at a constant temperature
of 300 K and a constant pressure of 1 bar. The temperature was regulated using the Langevin thermostat with a collision frequency of 1.0 ps-1. The trajectories were saved every 500 steps (1 ps).
AutoDock Vina (154) was used to dock compounds C – F into the active site of CypA and Gauss
View 3.09 (164) was used to build the different inhibitors shown in Figure 13. The inhibitors represent a
collection of nonpeptidomimetic CypA inhibitors from the literature, with each inhibitor representing
the compound with the highest activity within its class. The nonpolar hydrogen atoms were merged to
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the corresponding heavy atoms. Gasteiger charges were added to the protein and inhibitors using AutoDock ADT. The inhibitors were docked to an ensemble of CypA conformations, obtained from the molecular dynamics simulation. Every other 10 conformations of CypA from the MD trajectories were used
in the docking studies. The docking parameters were set at follows: the grid spacing was 1.0 Å; the box
size was 25 Å in each dimension, and the center of the box was chosen so as to have all of the active site
residues within the box. The maximum number of binding modes saved was set to 10. The configuration
of the inhibitor in the active site with the lowest binding energy was assumed to be the best binding
mode for that conformation of CypA. The most probable binding mode was assumed to be the correct
binding mode and was used to carry out molecular dynamics simulation on the CypA-inhibitor complex.
The MD simulations were carried out as described above. The force field parameters for the inhibitors
were derived using the Antechamber module in Amber. The ability of AutoDock Vina to provide the correct binding modes of compounds C – F was validated by redocking compounds A and B to the single
conformation of the respective crystal structures and an ensemble of conformations of CypA that was
generated using molecular dynamics. The binding modes obtained using AutoDock Vina were similar to
the binding modes of compounds A and B in the active site of CypA in the crystal structures (Figure C1).
4.5
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5

JUXTAPOSING THE MECHANISMS OF HUMAN CYCLOPHILINS A AND B
Enzymes speed up the rate of a specific chemical reaction by selectively binding their substrates

and subsequently lowering the activation energy of the targeted reaction. Some enzymes correspond to
only one genotype encoding one type of chemical reaction (e.g. acetyl-CoA synthetase), whereas other
types of enzymes have many genotypes (or isoforms) encoding one type of chemical reaction, resulting
in a family of enzymes. The cyclophilins are an example of such a family of enzymes. Cyclophilins catalyze the cis/trans isomerization of peptide bonds found in X-Pro motifs, where X can be any amino acid.
The cyclophilins are a part of the peptidyl-prolyl cis/trans isomerase (PPIase) enzyme superfamily. Cyclophilins are ubiquitous enzymes that vary in abundance and cellular localization among tissue and organism types (16). The catalytic PPIase domains have well-conserved tertiary structure and active site
residues (17).
Peptidyl-prolyl cis/trans isomerization has evolved to function as a molecular switch, and enzymes that catalyze this reaction can regulate the functions of their target proteins (165, 166). The SH2
domain of interleukin-2 tyrosine kinase (Itk) undergoes proline isomerization at the N286-P287 ω-bond.
When this ω-bond is in the trans conformation, Itk forms as intermolecular interaction between the SH2
and SH3 domains (167). The receptor 5-hydroxytryptamine type 3 (5-HT3) can bind serotonin when the
ω-bond of P8 is in the cis conformation, but results in a loss of functionality when P8 is in the trans conformation (168). The signal transducing protein Crk can bind its peptide substrate when its G237-P238
ω-bond is in the trans conformation, but forms tight intramolecular interactions between the SH2 and
SH3 domains when this ω-bond is in the cis conformation (169). Prolyl isomerization has also been identified as a rate-limiting step in protein folding, (170) and proline peptide bonds are found in type-I beta
turns (the most common type) (171, 172). These examples indicate that the efficiency of this isomerization reaction affects transport across cellular membranes, signal transduction, and the native conformation of proteins.
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Six of the cyclophilin family members are monomeric enzymes with a single PPIase domain,
while the other members of the cyclophilin family contain domains with different functions (16). Human
cyclophilins A and B (CypA and CypB, respectively) are two of the six monomeric cyclophilins. There are
a few pieces of evidence suggesting that these two enzymes have differences in their catalytic function.
Compared to CypA, the amino acid sequence is 64% conserved in CypB, and CypB (~23 kDa) is slightly
larger in mass than CypA (~18 kDa) (16). CypA is a cytosolic protein, while CypB is localized to the endoplasmic reticulum by an N-terminal signal sequence and participates in the secretory pathway. They
have slightly different catalytic efficiencies – CypA has a kcat/KM value of 1.6 x 107 M-1s-1, and CypB has a
kcat/KM value of 6.3 x 106 M-1s-1(33). CypA is three-fold more sensitive than CypB to the immunosuppressive inhibitor cyclosporine A (CsA) (173). Moreover, CypA and CypB have unique functions in the immune system. Memory T-cells can adhere to the extracellular matrix by two different mechanisms
where the type I binding mechanism involves endocytosis of CypB into the T-cell (174). Also, CypB can
bind a receptor on platelets (175), while CypA has not been shown to participate in T-cell adhesion or
platelet binding. However, CypA also exerts some immunological effects by acting as a chemoattractant
for interleukin-6 and monocytes (119). This data suggests that cyclophilin isoforms can regulate the immune system in various ways, further justifying their classification as immunophilins.
Elucidating the mechanism of cyclophilin function is important due to the roles that CypA and
CypB play in a variety of diseases. Due to gene upregulation, CypA can serve as a prognostic marker for
several types of cancer, including pancreatic, breast, liver, colorectal, and lung cancers (29). CypB has
also been proposed to be a prognostic marker for pancreatic, breast, colorectal, and bone cancers (29,
176). Downregulation of the CypA gene via RNA interference inhibits tumor growth and induces apoptosis in endometrial carcinoma, and cyclophilin inhibition was found to induce apoptosis in both glioma
and hepatocellular carcinoma cells (119). CypA and CypB play various roles in breast cancer progression:
CypB binds the hormone prolactin (177), and CypA forms a protein-protein interaction with the trans-
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membrane prolactin receptor (178). Mutations in the CypB gene have been linked to underdevelopment of the skeletal system in a potentially lethal condition known as osteogenesis imperfecta(179).
Cyclophilin function is also utilized by a number of viruses. Although both CypA and CypB can bind to the
HIV-1 capsid protein in vitro (114), only the interaction with CypA has been found to make a significant
impact on HIV-1 proliferation via its subsequent packaging into HIV-1 virions(180). CypA can also bind to
the capsid protein of the SARS coronavirus, but this interaction has not yet been linked to virion function(120). Both CypA (26) and CypB (181) can form a protein-protein interaction with the NS5B RNA polymerase of the Hepatitis C virus. CypB has also been identified as playing a critical role in the proliferation of human papilloma type 16(182) and Japanese encephalitis(183) viruses; however, CypA could not
be ruled out as also participating in the equivalent reactions for these two cases. Therefore, inhibiting
one cyclophilin isoform for medical treatment may result in more effective targeting of a given condition
and fewer side effects than using a global cyclophilin inhibitor (123).
We have set out to gain insight into why nature has provided us with so many genes that can
perform the same general function. Is it solely for the sake of efficiency that intracellular localization can
provide, or is it due to slight modifications in function that have yet to be discovered? There are enzyme
isoforms in other enzyme families that have been identified to have variation in function. The type-1
isoform of 11β-hydroxysteroid dehydrogenase can activate glucocorticoids, while the type-2 isoform of
this enzyme inactivates glucocorticoids in certain tissues (184). Cyclooxygenase isoforms 1 and 2 (COX-1
and COX-2, respectively) both regulate neurons in the gastrointestinal tract, but COX-1 is linked more
closely to neuronal responses while COX-2 is linked more closely to muscular responses (185). Three
isoforms of adenosine monophosphate deaminase were found to have different binding affinities for
actomyosin (186). All of these examples suggest that a family of enzymes may utilize their family members to regulate a chemical reaction in different ways. However, functional variation in the PPIase domain of cyclophilin isoforms has yet to be discussed.
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Here, we use all-atom molecular dynamics (MD) to investigate the differences in catalytic mechanisms of CypA and CypB. Molecular dynamics captures conformational changes in atomistic detail that
allows us to observe even the slightest differences between the two enzymes. Both enzymes are compared in the apo state and while complexed to the model tetrapeptide substrate analogue Ace-Ala-AlaPro-Phe-Nme. In order to gain a better perspective of what occurs along the reaction coordinate during
catalysis, we analyze the enzyme-substrate complex when the substrate is in the cis (ω = 0˚), trans (ω =
+180˚), and transition state (ω = 90˚) configurations. We use normal MD to sample enzyme motions, and
accelerated MD to observe how various degrees of freedom in cyclophilin complexes change along the
reaction coordinate. In this work, we are also interested to know if these two enzymes have key contrasts in functional dynamics, even though active site residues are completely conserved. Also, we include commentary about what may need to be exploited in order to selectively target one of these two
enzyme isoforms via drug design.
5.1

Methods
Simulations were performed using the AMBER 10 suite of programs (163) using the ff99SB force

field (39) and re-optimized parameters for the ω-bond torsional angle (41). X-ray crystallographic protein structures were taken from the Protein Databank for CypA (PDB # 1AWR) (25) and for CypB (PDB #
1CYN) (187). The PDB structure of CypA used here is complexed to the substrate Ace-His-Ala-Gly-Pro-IleAla-Nme in the trans conformation, and the PDB structure of CypB is complexed to CsA. The xleap module in AMBER 10 was used to modify the substrate atoms of CypA to match the substrate analogue AceAla-Ala-Pro-Phe-Nme, and the molecule of cyclosporine was manually removed from the CypB PDB file.
PyMOL (188) was used to superimpose the structures of the two enzymes with the substrate analogue
bound to the active site, and the new coordinates of the substrate analogue were appended to the CypB
PDB file. The CypA complex was solvated with approximately 5500 TIP3P water molecules and neutralized with four chloride ions. The CypB complex was solvated with approximately 5800 TIP3P water
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(38)molecules and neutralized with seven chloride ions. It is important to note that the crystal structure
of CypB is lacking the portion of the protein that keeps CypB anchored to the membrane of the ER, starting at the glycine positioned immediately after the polylysine sequence –ADEKKK (173). The numerical
indices used in this work for the primary amino acid sequences of CypA and CypB are the result of the
alignment with PyMOL and xleap.
First-order minimization is performed for 1000 steps to relax each system to the lowest-energy
native conformation, using a force constant of 100 kcal/mol/Å2. This is followed by two MD simulations
(300 picoseconds total) that introduce the isothermal-isobaric ensemble and begin to integrate Newton’s second law of motion, further relaxing the system by reducing the force constant from 100
kcal/mol/Å2to 20 kcal/mol/Å2. The temperature is maintained at approximately 300 K using Langevin
dynamics (collision frequency = 1 ps-1) and a pressure of 1 bar is used in all simulations. Equilibration was
then carried out for 200 picoseconds. After equilibration, the pmemd module of AMBER 10 is used to
carry out the MD simulations. Newton’s equations of motion are integrated at a time step of two femtoseconds. The SHAKE algorithm (46) is used in all simulations to restrain the oscillation of all covalent
bonds containing a hydrogen atom. Long-range electrostatic interactions are treated using particle-mesh
Ewald summations(47-49), and the non-bonded interaction cutoff distance is maintained at 9 Å.
Normal MD simulations were produced for apo CypA and apo CypB, as well as CypA and CypB
complexed to the substrate analogue in the trans, transition state, and cis configurations. The apo enzymes were both simulated for at least 300 nanoseconds each. A minimum of three independent normal
MD simulations were produced for both of the enzymes complexed to each of the three configurations
of substrate for at least 100 nanoseconds per simulation (resulting in a minimum total of 18 normal MD
simulations). We use a flat-bottom well torsional restraint to hold the ω-bond at 90˚ when simulating
the transition state, with a force constant of 1000 kcal/mol/Å2. The conformation of the substrate found
in the crystal structure is trans, so no modification was needed to simulate the trans enzyme-substrate
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complexes. To shift the substrate to the cis conformation, we equilibrate the enzyme-substrate complex
with the same harmonic restraint to hold the ω-bond at 0˚, and then the complex is simulated with no
restraint.
Accelerated MD simulations (50) were run for the free substrate, the CypA enzyme-substrate
complex, and the CypB enzyme-substrate complex starting with the substrate in the trans configuration.
Five independent accelerated MD simulations were produced for each of these three systems, with each
simulation being 0.2 μs long, resulting in a total of 15 accelerated MD simulations. To accelerate the system, we applied a boost energy (E) of 103 kcal/mol and a tuning parameter (α) of 15 kcal/mol. Each
sampled conformation of the ω-bond is reweighted with the Boltzmann factor of the modified potential,
exp[-βΔV(r)], which is considered in each distribution generated by accelerated MD(51). All energycontoured plots were calculated using this Boltzmann probability and represent the average results of
five independent accelerated MD simulations. All of the other data shown are a result of normal MD
simulations.
Principal component analysis (PCA) was performed on both of the enzyme backbones, as well as
their hydrophobic and hydrophilic pockets via the ptraj module in AMBER 10. Ptraj was used to calculate
the covariance matrix of the Cartesian coordinates of the atoms of interest, as well as to project the
principal components back onto the data set. The formulae used in the application of PCA have been
extensively discussed (52, 189). The results of PCA for the enzyme backbone were visualized using interactive essential dynamics (IED) (190) which allows the motions of each eigenvector to be viewed on the
topological structure in the VMD (106) graphical user interface. The ptraj module of AMBER 10 also
handles all basic atomic calculations, including order parameters of backbone amide bonds, root mean
square fluctuations of alpha carbons (Cα), residue correlations, dihedral angle values, and hydrogen
bond distances in the normal MD simulations. PCA was also performed on all of the distances between
the Cα’s of the residues forming the hydrophobic and hydrophilic pockets. Since each pocket contains 10
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residues, there are a total of 45 Cα to Cα distance measurements per pocket. The distance measurements for the apo, trans, transition state, and cis ensembles of CypA were combined before calculating
the covariance matrix and projecting orthonormal vectors onto the data using MATLAB software, and
likewise for CypB.
The POVME algorithm (191) was used to measure the pocket volume of each enzyme’s hydrophobic and hydrophilic cavity. The region set to encompass the pocket was an inclusive sphere with a
radius of 5 Å and an inclusive box with dimensions 5 Å by 5 Å by 5 Å. The center of the box and sphere
was set to equivalent Cartesian coordinates, which were chosen by taking the mean coordinates from
the positions of all of the Cα’s of the residues forming the pocket. For the bound enzyme-substrate
complexes, the substrate was stripped from each frame along the trajectory before proceeding with the
volume calculation. Discontinuous regions of volume were removed by keeping an inclusive sphere of 4
Å in which the volume region is contiguous.
5.2

Enzyme dynamics of CypA and CypB during substrate recognition and catalysis
The most empirical treatment of enzyme binding is the lock-and-key model (192), because it as-

sumes a rigid treatment of the receptor and its binding target.(193) The scientific realm is now aware
that biomolecular systems are not static, but instead are dynamic processes dependent on reactivity,
diffusion, and conformational change. (193, 194)Truly identifying differences in the mechanisms of two
enzymes that perform the same catalytic function requires multiple simulations of critical points along
the catalytic pathway. We consider the critical points of cyclophilin substrate recognition and catalysis to
be captured in the apo, trans, transition state, and cis conformational ensembles. We use principal
component analysis (PCA) to probe the inherent dynamics of CypA and CypB enzyme backbones (Fig.
20). PCA captures the spread within any given multidimensional data set via two critical steps – (1) normalizing the data around the mean by generating a covariance matrix from the input, then (2) projecting
orthogonal unit vectors onto the covariance matrix in a linear algebraic fashion, such that the first few
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projected vectors capture the most spread in the data. Therefore, the first principal component (PC1)
corresponds to the most dominant motion of the system, and principal components are ranked accordingly. For CypA (Fig. 20A and 20C), the dominant motions of the enzyme backbone are very similar for
the trans and cis complexes, while the transition state complex takes on more distinguishable motions.
However, the motions of the enzyme backbone in the trans and cis complexes of CypB are more distinguishable from each other (Fig. 20B and 20D), while the backbone motions of the trans and transition
state complexes of CypB share significant overlap and similarity. The volume of the grid containing the
CypA backbone data is 146,250 Å3 and the top three principal components capture 58% of the total variance; likewise, the volume of the grid containing the CypB backbone data is 63,000 Å3 and the top three
principal components capture 57% of the total variance. Unique enzyme motions are sampled in each
conformational ensemble, indicated by the distinguishable non-overlapping regions. For both CypA and
CypB, the apo ensemble samples more vast conformational space than the bound ensembles, which
indicates that the formation of intermolecular contacts restricts enzyme motion.
We use interactive essential dynamics (IED) (190) to project each eigenvector generated by PCA
onto each trajectory and visualize the effect on the topological structure of the enzyme. We have generated several structures, highlighting the top three dominant motions of each enzyme in the apo¸ trans,
transition state, and cis ensembles (Figs. 21 and 22). The initial position of the trajectory is represented
in red and the final position is represented in royal blue. The overlapping of several frames along the
trajectory results in gradations of these two colors when the initial and final atomic positions overlap
with positions sampled along the trajectory.
Dynamic motions are the most dominant in the solvent accessible loop regions of cyclophilin.
The motions in the surface loop regions of CypA are more global in the first principal component, and
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Figure 20
Figure 20. Three dimensional projection of the top three vectors from a principal component analysis of the
CypA and CypB enzyme backbone including only N, Cα, C, and O atoms.
The front and back of the PCA data are shown for CypA in panels A and C and for CypB in panels B and D
respectively. The results for the apo enzyme are shown in black, the trans complex is shown in red, the transition
state complex is shown in green, and the cis complex is shown in blue.
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become more localized in the less dominant motions of the system (Fig. 21). Along PC1, all of the structural regions showing significant displacement are consistent in each of the four ensembles. However,
the motions in these regions exhibit larger displacements in the apo enzyme and become more localized
in the bound ensembles. Along the second principal component (PC2), only two of these structural regions identified in PC1 maintain significant dynamic motion during simulation. Along the third principal
component (PC3), more surface loops show dynamic fluctuations in the apo¸trans, and transition state
ensembles, but the cis ensemble is more restricted in motion. Loop region 146-156, which sits on top of
the enzyme with respect to the active site, fluctuates vertically in PC2 but fluctuates horizontally in PC3.
The trans complex of CypA preserves most of the large displacements sampled in apo CypA, while the cis
complex tends to sample smaller displacements in surface loop regions. The fluctuations of the transition state CypA complex ensemble reflect intermediate displacements in these regions compared to the
ground state complexes.
In contrast, the surface loop regions of CypB exhibit increased flexibility in the less dominant
motions of the CypB enzyme backbone (Fig. 22). Along PC1, few surface loop regions show small, localized displacements in apo CypB that become more restricted in motion in the bound ensembles. Along
PC2, there are more surface loops that show larger displacements along the enzyme backbone. Along
PC3, the same surface loops identified in PC2 show even larger displacements resulting from dynamic
motion. This indicates that longer range motions of the CypB backbone occur at a lower frequency than
the smaller localized fluctuations sampled in the most dominant motions. CypA, however, tends to predominantly exert global fluctuations which become restricted to certain regions of the enzyme in the
less dominant motions of the backbone. The residues participating in the notable displacements along
the enzyme backbones have been tabulated in supplementary materials (Fig. D1 and D2).
Networks on intramolecular interactions found in pathways of propagated motions have been
proposed to contribute to the catalytic step of cyclophilin. (70) Therefore, a significant contributing fac-
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tor to variation in enzyme dynamics arises from unique intramolecular interactions. Intramolecular interactions can be analyzed on the enzyme globally by cross-correlation maps, which we have generated
for each of the four ensembles of CypA and CypB (Fig. D3 and D6, respectively). Positive correlations
indicate that enzyme residues move together during the simulation, and are the result of secondary
structure regions that are sterically close (Fig. D4). Negative correlations reveal residues that tend to
move apart during the simulation, and these plots depict the average behavior of the normal MD simulations. The negative correlation reaches a minimum of ~0.5, although most of the enzyme remains at a
correlation value of ~0.2 or greater. Cyclophilin is a closed β-barrel, meaning that the two α-helical regions that flank the β-barrel keep it from forming the well-known open β-barrel structure. The two perpendicular β-sheet regions on the enzyme tend to move apart, as well as several loop regions on the
enzyme (Fig. D5). When CypA is bound to the trans and cis substrate configurations, it preserves most of
the correlated motions found in the apo state. However, when CypA is bound to the transition state, it
takes on unique correlated motions. This is due to loop region II becoming more flexible and resulting in
more anti-correlation with various enzyme regions in CypA. In CypB, regions with negative correlations
are reduced back down to the ~0.2 regime although the positively correlated regions are roughly the
same as those in CypA. Negative correlations in CypB residues involve the tail ends of the enzyme, as
well as a small region between 68 to 78 and residues 155 to 160 in the cis CypB-substrate complex.
To contrast a global view with one that is more residue specific, we also employ two common
methods for probing the intrinsic flexibility of each enzyme – (1) measuring the root mean square fluctuations (RMSF) of the enzyme residues at Cα and (2) measuring the order parameters from a one picoseconds relaxation of the backbone amide bonds. The order parameters (S2) presented here are the
theoretical components of the NMR order parameters, obtained from the decay of the individual autocorrelation functions associated with the motion of each backbone amide bond. (195) Here, we show
the percent change in both S2 and RMSF values upon binding the substrate in the trans, transition state,
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Figure 21
Figure 21. Structural regions affected by the top three dominant motions of the apo, trans, transition state, and
cis ensembles of CypA, obtained by interactive essential dynamics.
CypA tertiary structures are shown in ribbon representation. For each ensemble, structures are overlaid every 1 ns
for the 300 ns of simulation length, with initial positions of the trajectory shown in red and positions near the end
of the trajectory shown in blue.
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Figure 22
Figure 22. Structural regions affected by the top three dominant motions of the apo, trans, transition state, and
cis ensembles of CypB, obtained by interactive essential dynamics.
CypB tertiary structures are shown in ribbon representation. For each ensemble, structures are overlaid every 1 ns
for the 300 ns of simulation length, with initial positions of the trajectory shown in red and positions near the end
of the trajectory shown in blue.
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and cis configurations for both CypA (Fig. 23) and CypB (Fig. 24), with structural regions showing significant changes highlighted on each enzyme.
Consistently, four structural regions show significant changes in RMSF and S2 value along the cyclophilin domain; we present these as regions I-IV. Region I consists of a large loop region from residues
66-96 in CypA (residues 68-98 in CypB) that flanks the sides of the monomer. Region II corresponds to a
loop region from residues 101-111 in CypA (residues 103-113 in CypB) that connects the hydrophobic
and hydrophilic pockets around the active site cleft. This region contains residues A101/103, N102/104,
and A103/105 (for CypA/CypB respectively) which help form the bottom of the active site. Region III
consists of residues 120-127 in CypA (residues 122-129 in CypB) that contains one α-helical turn directly
in front of the active site, and contains active sit residues L122/124 and H126/128 (please note, this
connotation of active site residues conserved among CypA/CypB will be consistently used throughout).
This region also contains W121/123, which is on the periphery of the active site but still forms intermolecular interaction with the substrate. Region IV contains residues 146-155 in CypA (residues 148-158 in
CypB) and is the loop region that sits on the very top of the cyclophilin domain with respect to the active
site. CypB gains an extra residue due to an amino acid not found in the CypA sequence, D153. (187) To
make these distinctive regions prominent in the mind, the colors pink, cyan, black, and orange are used
for regions I-IV, respectively (Fig. 23 and Fig. 24). All of these loops are found on the solvent accessible
surface of the enzyme, and are also a subset of the regions identified in the IED results.
In both CypA and CypB, region I is a mixture of hydrophobic and hydrophilic residues that show
a mixture of fixation and flexibility upon binding the substrate. In CypA, region II becomes more flexible
upon binding the substrate (Fig. 23C); however, in CypB, region II becomes more fixed upon binding the
substrate (Fig. 24C). Region II can move from being pointed downward, away from the active site, to
moving more closely to the substrate which puts N102 in the proximity of forming a hydrogen bond with
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Figure 23
Figure 23. Percent change in (A) backbone amide bond order parameters and (C) root mean square fluctuations
of Cα’s in CypA.
Changes are shown relative to the apo ensemble, with curves for the trans (red), transition state (green), and cis
2
(blue)ensembles shown in panel A and C. Structural regions with significant changes in S value (B) and in RMSF
value (D) have been highlighted on the enzyme. In panel B, residues 77-95 are shown in pink (region I), residues
99-104 are shown in cyan (region II), and residues 145-151 are shown in orange (region IV). In panel D, residues 7692 are shown in pink (region I), residues 98-113 are shown in cyan (region II), residues 121-131 are shown in black
(region III), and residues 142-157 are shown in orange (region IV).
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Figure 24
Figure 24. Percent change in (A) backbone amide bond order parameters and (C) root mean square fluctuations
of Cα’s in CypB.
Changes are shown relative to the apo ensemble, with curves for the trans (red), transition state (green), and cis
2
(blue)ensembles shown in panels A and C. Structural regions with significant changes in S value (B) and in RMSF
value (D) have been highlighted on the enzyme. In panel B, residues 75-95 are shown in pink (region I), residues
102-108 are shown in cyan (region II), residues 120-130 are shown in black (region III), and residues 155-160 are
shown in orange (region IV). In panel D, residues 80-92 are shown in pink (region I), residues 98-112 are shown in
cyan (region II), residues 119-129 are shown in black (region III), and residues 145-158 are shown in orange (region
IV).
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the amino acid preceding the substrate Pro. This loop region is completely conserved with the exception
of two consecutive residues – P105 and N106 in CypA are analogous to K107 and D108 in CypB. This
promotes salt bridging between the two residues K107 and D108, which modifies the dynamics of the
loop accordingly. Loop region III shows similar behavior in both enzymes, where W121/123 becomes
more fixed upon binding the substrate; however, H126 becomes more flexible upon CypA binding the
trans substrate (Fig. 23C) and this effect is not as pronounced for H128 in CypB. Region IV becomes
more fixed upon CypA binding the substrate. This is mostly due to the primary sequence variation of this
region; only one residue in this region is conserved between both enzymes. D153 (which is unique to
CypB) can form a salt bridge with R57 and when it is formed, region IV can move from left to right along
with the motion of the R57 side chain. However, when it is broken, region IV can move up and down.
Flanking D153 are the residues R152 and K154, and these positively-charged residues occasionally form
van der Waals contacts along the aliphatic portions of their bulky side chains. It is the up and down, left
to right and twisting motions induced by these intramolecular interactions that cause region IV in CypB
to be so highly flexible. The significance of the formation of these intramolecular salt bridges on enzyme
dynamics are discussed further on.
The residues that show significant change in flexibility are modulated as the substrate changes
conformation along the catalytic step. The backbone amide bond of E81 becomes more flexible when
CypA binds the trans substrate, but the backbone amide bonds of F83, T93, N102, and G150 become
more fixed (Fig. 23A). Upon CypA binding the substrate in the transition state, the backbone amide
bonds of E81 and G104 become more flexible and the backbone amide bonds of F83, T93, and G150 become more fixed. The flexibility in the backbone amide bond of E81 is reduced approximately two-fold
compared to when CypA binds the trans substrate, and the backbone amide bond of N102 becomes
fixed due to forming a hydrogen bond with the substrate backbone. And upon CypA binding the substrate in the cis conformation, the backbone amide bonds of G104 become more flexible and F83 and
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G150 become more fixed. G104 becoming more flexible in the transition state and cis complexes could
be coupled with the formation of stronger intermolecular contact between the active site residues
A101, N102, A103, and the substrate. When CypB binds the trans substrate, backbone amides of residues N89 and G106 become more flexible and backbone amides of residues K78 and K91 become more
fixed. For the formation of the CypB transition state complex, backbone amide bonds of residues N89
and G106 become more flexible, and backbone amide bonds of residues K78, K91, and W123 become
more fixed. Lastly, when CypB binds the cis substrate, the backbone amide bond of E83 becomes more
flexible and the backbone amide bond of K91 becomes more fixed.
Fixation of the backbone amide bonds does not infer fixation of the side chains (and likewise for
flexibility), as indicated by RMSF values. Upon CypA binding the trans substrate, the Cα’s of residues
E81, K82, F83, and G150 become more fixed, and the Cα’s of residues N102, G104, P105, N106, T107,
and H126 become more flexible. Upon CypA binding the transition state, P105, N106, and T107 show
substantial increase in flexibility, as well as Cα’s of G80 and E84 becoming slightly more flexible. Upon
CypA binding the cis substrate, only K82 becomes more fixed and only I89 becomes more flexible. When
CypB binds the trans substrate, no Cα’s become significantly more fixed, but the Cα’s of residues N89
and D153 become more flexible. When CypB binds the transition state, the Cα’s of residues F85, P86,
D108, and W123 become more fixed and Cα of D153 becomes more flexible, but is reduced six-fold in
flexibility compared to forming the trans complex. When CypB binds the substrate, no Cα’s become significantly more fixed, but the Cα’s of residues E83, N89, F90, L92, and D153 become more flexible. The
flexibility of D153 in the cis complex is about 2.5-fold increased compared to the transition state complex, but also about 2.5-fold reduced compared to the trans complex. CypB residues K78, F85, K91, L92,
N110, and W123 are also conserved in CypA, but do not show significant change in S2 or RMSF value in
CypA. Likewise, N102 in CypA is also conserved in both enzymes but does not show significant change in
S2 or RMSF in CypB.
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The amino acid composition of CypB contains more acidic and basic residues in comparison to
CypA (i.e., Lys, Arg, Asp, and Glu residues), most of which are on the solvent accessible surface. CypA
and CypB both have an overall net positive charge, but CypA requires four chloride counterions to bring
the system to neutrality while CypB requires seven. This increase in acidic and basic character increases
the propensity for salt bridge formation. We have identified several salt bridges that contribute to altered or distinguishable dynamics in each enzyme (Fig. 25). The residue D153 (mentioned above) which
is only encoded for in CypB can form an intramolecular salt bridge with R57 (Fig. 25A). This interaction is
well formed in the apo enzyme, but weakens once the substrate is bound. This weakening is most likely
due to R57 forming its classic hydrogen bond with the substrate Pro, which has been noted for CypA
several times (13, 33, 35) and is also conserved in CypB. It is possible that the intramolecular salt bridge
causes R57 to compete with forming the canonical hydrogen bond with the substrate Pro, which could
contribute to the difference in turnover number. Two residues in CypB that lie along the loop region II,
K107 and D108, form salt bridges with two residues that lie along loop region I: D87 and R84, respectively (Fig. 25B and 25D). These two contacts cannot form in CypA because P105 and N106 are analogous to
CypB residues K107 and D108 (Fig. 25C). In apo CypB, these salt bridges are well formed, but upon binding the substrate, the salt bridge between K107 and D108 dominates and promotes the flexibility of loop
region II. Lastly, a salt bridge between E83 and R84 in CypB (Fig. 25E) has a better propensity to form
than the analogous salt bridge between E81 and K82 in CypA (Fig. 25F). This intramolecular contact affects the shape of a hydrophilic cavity adjacent to the active site which can be useful for cyclophilin inhibition and isoform discrimination. (196) This data demonstrates that differences in primary sequence of
two enzyme isoforms leads to variation in intramolecular interactions, which allows for dynamics to be
modulated as conformational states are populated.
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Figure 25
Figure 25. Intramolecular interactions that contribute to the unique dynamics of CypA and CypB.
Note that some interactions are consistently formed in the apo (black), trans (red), transition state (green), and cis
(blue) ensembles while others vary with substrate conformation. The interactions presented here are for the following residues (with participating atoms labeled in parentheses): 25AArg 57 (CZ) – Asp 153 (CG); 25B Lys 107 (NZ)
– Asp 87 (CG); 25C Lys 107 (NZ) – Asp 108 (CG); 25D Arg 84 (CZ) – Asp 108 (CG); 25E Glu 83 (CD) – Arg 84 (CZ); 25F
Glu 81 (CD) – Lys 82 (NZ). Intramolecular contacts 25A – 25E are in CypB, and contact 25F is in CypA.
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5.3

Variations in active site conformational dynamics in CypA and CypB
We have previously shown that cyclophilin dynamics are sensitive to and can be modulated by

the conformation of the substrate. (73, 197) Because the active sites and secondary structure are completely conserved, the notable differences in enzyme dynamics are mostly caused by the unique residues in each isoform sequence. Active site residues are R55/57, F60/62, M61/63, Q63/65, A101/103,
N102/104, A103/105, F113/115, L122/124, and H126/128 for CypA/CypB respectively which are no
more than four Angstroms away from the rotating ω-bond of the substrate. These residues have been
well documented in literature and comprise the proline binding pocket. (17, 33, 44, 70) We use PCA to
probe changes in cavity shape as well as the motions of the side chains composing the active site, and to
determine how correlated bound and apo conformations of the active site are in an effort to understand
coupling between binding and conformational change. To define cavity shape, we measure all of the
atomic distances between the Cα’s of the ten active site residues over the course of all trajectories, resulting in 45 distance measurements (Fig. 26A and 26B).
For both CypA and CypB, the cavity shapes of the hydrophobic pocket are coupled in the apo¸
trans, transition state, and cis ensembles. A subset of the cavity shapes sampled in apo CypA are shared
with the bound ensembles of CypA (Fig. 26C). The biggest differences in the cavity shape of the CypA
ensembles are captured in PC1; the CypA ensembles share significant overlap along PC2 and PC3. As
CypA goes from the apo state to a bound complex, values along PC1 become more negative and are the
most negative in the transition state ensemble. This indicates that the cavity shape of the CypA hydrophobic pocket is becoming tighter, since the Cα distances are smaller than average. In CypB, the cavity
shape stays approximately the same when the substrate is bound regardless of the substrate conformation, and all of the bound cavity shapes can also be sampled by the apo enzyme (Fig. 26D). The volume of the grid in Fig. 26C is 3,456 Å3 and the top three principal components capture 84% of the
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Figure 26
Figure 26. Three dimensional projection of the top three vectors from a principal component analysis of the hydrophobic pockets of CypA and CypB.
The hydrophobic pockets are shown on the CypA (26A) and CypB (26B) structures. Principal component analysis
was performed on the inner pocket α-carbon distances of CypA (26C) and CypB (26D) hydrophobic pockets, as well
as the Cartesian coordinates of the side chains composing the hydrophobic pockets of CypA (26E) and CypB (26F),
measured throughout the course of the trajectories. The results are black for apo Cyp, along with each Cyp complexed to the trans (red), transition state (green), and cis (blue) substrate configurations. All Cα’s are shown in
blue, with the atomic distances between them shown in red.
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total variance; likewise, the volume of the grid in Fig. 26D is 4,536 Å3 and the top three principal components capture 79% of the total variance. The conformational space sampled by CypA and CypB when
bound to the substrate reveals that each enzyme interacts with the trans and cis conformations of substrate differently.
The major motions affecting atomic distances depend on less degrees of freedom than those affecting the position of full length side chains. Therefore, the conformational space sampled by the full
length side chains of the active site yields different results from those of the Cα distances. There are apo
conformations of the active site in both CypA and CypB that overlap with bound active site conformations, demonstrating that apo cyclophilin can sample active site conformations that effectively bind
the substrate. The active site of apo CypA appears to sample two states that flank each side of the
bound ensembles (Fig. 26E), and the rarely populated state corresponds to tightly formed conformations where R55 is in the primed position to hydrogen bond with the substrate at the prolyl oxygen.
The more densely sampled conformations of apo CypA correspond to conformations of the active site
where some (if not all) of the hydrogen bonds can form with the substrate, as well as those conformations where the active site cavity is not well formed at all. Those apo active site conformations that
are somewhat well formed tend to overlap with the bound ensembles of the active site, while those that
are not well formed at all lie on the outer edge of the densely populated space.
There are key motions of the active site that each conformational ensemble depends on with
different levels of dominance. The first and most notable motion of the CypA active site is the motion of
R55. The large side chain of R55 can swing up and down, away from and towards the active site, respectively. The downward position primes the guanidinium group of R55 to hydrogen bond with the substrate. The apo, transition state, and cis ensembles exert this motion in PC1, but the trans ensemble exerts this motion in PC3. This motion is also sampled in PC2, but not to the same extent or range of displacement found in PC1. The side chain of R55 can also swing from left to right, and this motion is preva-
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lent in the apo, transition state, and cis ensembles of PC3. Another key motion of the CypA active site
involves the side chain of F60. Not only can the phenyl ring of F60 swing inward and outward from the
active site, but it can also flip ~90˚, making the phenyl ring parallel with the active site. This flipped conformation of F60 is sampled by only the transition state ensemble in PC1, as well as the cis ensemble in
PC3. The swinging of the phenyl ring causing it to be pointed towards and away from the active site affects how tightly the proline binding pocket is shaped, with the inward conformation corresponding to a
better formed pocket. This swinging motion is sampled in PC2 by the transition state and cis ensembles,
as well as the apo and transition state in PC3. Lastly, another key motion of the CypA active site involves
loop region II. Kinks are introduced into this loop region during sampling that cause it to shift from being
in the downward position found in the crystal structure to being pointed upward, or to become parallel
with the orientation of the substrate. Flexibility in residues G104, P105, N106, and T107 (as noted
above) promote this shift. The parallel conformation of loop region II is sampled by the trans and transition state ensembles in PC1. Kinks promoting this shift are found in PC2 for all of the CypA active site
ensembles, and in PC3 for all of the bound ensembles of the CypA active site. These motions have been
graphically depicted in appendixD (Fig. D7).
In CypA the proline binding pocket can become malformed, but in CypB the proline binding
pocket remains well formed, meaning that the active site residues are arranged in a compact conformation that optimizes binding of the proline ring. The conformational spread sampled by the full length
side chains of the CypB active site arises from the same key motions noted for the CypA active site, but
the behaviors of these select regions contributing to the dominant motions are modified. For the active
site of apo CypB, rarely populated conformations and densely populated conformations are not as distinguishable (Fig. 26F). As noted above, the motion of R57 is limited by intramolecular interactions with
D153. Therefore, the side chain cannot move as far upward as R55 in CypA can move, although it can
still move downward in order to hydrogen bond with the substrate. For CypB, the motion of R57 is criti-
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cal to all of the conformational ensembles in all of the top three principal components. In PC1 of the
CypB active site, the motion of R57 is the only significant displacement found in the trans and transition
state ensembles. The motion of F62 also contributes to the dominant motions of the CypB active site,
and is sampled in PC1 of the cis ensemble as well as in PC2 of the apo ensemble. Kinks are also introduced in loop region II of CypB, and this loop can change its spatial volume by forming and breaking the
intramolecular salt bridge between Lys 107 and Asp 108. When the salt bridge is broken, the loop samples wider volumes than when the salt bridge is formed, possibly facilitating its motion and fixation in
the CypB transition state complex. Kinks in loop region II are sampled in PC1 of the cis ensemble, in PC2
of the trans and cis ensembles, and is sampled in every ensemble for PC3. Although kinks in loop region
II are sampled in many ensembles, the loop never becomes parallel with the substrate orientation as it
does in CypA. The volume of the grid in Fig. 26E is 61,250 Å3 and the top three principal components
capture 66% of the total variance; likewise, the volume of the grid in Fig. 7F is 198,000 Å3 and the top
three principal components capture 57% of the total variance.
Located adjacent to the hydrophilic proline binding pocket is another pocket which is more hydrophilic in nature. This pocket consists of residues G74/76, G75/77, E81/83, K82/R84, M100/102,
T107/109, N108/110, G109/111, S110/112, and Q111/113, for CypA/CypB respectively. Extending our
PCA methodology out a final time to the hydrophilic pockets of CypA and CypB, we perform PCA on all of
the atomic distances between all Cα’s of the residues forming the hydrophilic pocket (Fig. 27A and 27B)
and on the Cartesian coordinates of all of the atoms in the hydrophilic pocket. In CypA, there are more
distinguishable cavity shapes in the transition state and apo ensembles in comparison to the trans and
cis ensembles (Fig. 27C). The CypA hydrophilic pocket is not always well formed, because the side chain
of K82 has more rotameric freedom and less electrostatic interaction with the rest of the enzyme than
the analogous R84 in CypB. Also, other residues nearby the ten residues defined here can stochastically
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Figure 27
Figure 27. Three dimensional projection of the top three vectors from a principal component analysis of the hydrophilic pockets of CypA and CypB.
The hydrophilic pockets are shown on the CypA (27A) and CypB (27B) structures. Principal component analysis was
performed on the inner pocket α-carbon distances of CypA (27C) and CypB (27D) hydrophilic pockets, as well as
the Cartesian coordinates of the side chains composing the hydrophilic pockets of CypA (27E) and CypB (27F),
measured throughout the course of the trajectories. The results are black for apo Cyp, along with each Cyp complexed to the trans (red), transition state (green), and cis (blue) substrate configurations. All Cα’s are shown in
blue, with the atomic distances between them shown in red.
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insert themselves into and out of the pocket during enzyme dynamics, which “breaks” the pocket and
creates the gaps found in the PCA space of the cavity shape. However, the residues noted here as forming the pocket are committed to the solvent accessible surface and fully form the cavity in the crystal
structure. In CypB, there is distinguishable sampling in cavity shape in the cis and apo ensembles in
comparison to the trans and transition state ensembles (Fig. 27D). This pocket is well-formed throughout the course of the simulations, because the side chain of R84 acts as a wall of the pocket and preserves the pocket shape. Occasionally the guanidinium group of R84 can insert itself into the pocket,
which does not abolish the cavity but significantly narrows it. The volume of the grid in Fig. 27C is 18,000
Å3 and the top three principal components capture 76% of the total variance; likewise, the volume of
the grid in Fig. 27D is 5,760 Å3 and the top three principal components capture 71% of the total variance.
We have previously demonstrated that experimentally resolved inhibitors of CypA can interact
with the hydrophilic pocket in silico. (196) These results support the hypothesis that targeting a cyclophilin isoform via inhibitor design may involve the use of this pocket. Therefore, the effective binding of
certain inhibitory drugs will be affected by the dynamics of this hydrophilic pocket in CypA. The dynamics ofthe hydrophilic pocket are more sensitive to the substrate conformation in CypA (Fig. 27E) than in
CypB (Fig. 27F). Along PC1, the major motion found in every conformational ensemble of CypA is the
insertion and removal of K82 into the pocket. Occasionally the side chain of K82 will be oriented away
from the enzyme, which breaks the pocket shape, but will reform the pocket by orienting the K82 side
chain close to or even inside of the hydrophilic cavity. The motion of K82 helping to form the pocket also
contributes to the transition state ensemble in PC2, and the apo and trans ensembles in PC3. In the
bound ensembles of CypA, a major motion of PC1 also involves the upward and downward motion of
loop region II, which has significant impact on the formation of the pocket because half of the residues
forming the pocket are contained within this loop. The cavity tends to be well formed when loop region
II is in the downward position (the position commonly found in crystal structures of CypA) but the cavity
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is broken when loop region II reorients itself upward, or twists to become parallel with the substrate.
This motion of loop region II is also a major contributor to PC2 in the transition state and cis ensembles,
as well as the transition state ensemble for PC3. Along PC2, a key motion found in every ensemble of
CypA except the trans involves salt bridge formation between E81 and R69. The displacement of E81 as
this salt bridge forms and breaks affects the shape of the hydrophilic pocket, and creates kinks in loop
region I which are present when the salt bridge is formed. This motion is also sampled by the transition
state ensemble in PC3. For CypB, there are significantly less notable motions that cause variation in the
conformational space sampled by the hydrophilic pocket. The major motion of the hydrophilic pocket
found in every principal component and in every conformational ensemble of CypB involves R84, as the
side chain switches between being oriented away from and pointing into the cavity. E83 can also break
away from the pocket and reorient more closely to form the pocket, as found in PC1 of the cis ensemble.
The twisting motion of loop region II that makes the loop parallel with the substrate is also sampled in
PC2 by the cis ensemble of CypB. However, this motion tends to be rarer for CypB than for CypA due to
the aforementioned difference in flexibility of loop region II demonstrated via RMSF calculations, and
also due to this difference the hydrophilic cavity of CypB tends to be better formed. The volume of the
grid in Fig. 27E is 315,000 Å3 and the top three principal components capture 74% of the total variance;
likewise, the volume of the grid in Fig. 27F is 94,500 Å3 and the top three principal components capture
74% of the total variance. These motions have been graphically depicted in supporting information (Fig.
S8).
Calculating the torsions of the residues in the hydrophobic and hydrophilic pockets along our
simulations reveals that only a subset of them contribute to the differences in dynamic behavior (Fig. S9
and S10). The residues with distinguishable torsional motions include R55/57, Q63/65, K82/R84,
N102/104, T107/109, N108/110, S110/112, and L122/124, for CypA/CypB respectively. The torsional
angles of R55 in CypA tends to sample the classic, low-energy, gauche rotamer conformations that are

96
indicative of rotation around a sigma bond, and this behavior deviates in the χ4 torsion due to the trigonal planarity of the guanidinium group. In CypB, the torsional angles of R57 are more restricted due to
tighter intramolecular interactions, and this causes the χ3 torsion to become more strongly coupled to
the rotation of χ4. Likewise, Q65 in CypB is more restricted in torsional freedom due to tighter intramolecular interactions compared to the analogous Q63 in CypA. The torsional angles of K82 in CypA and
R84 in CypB also sample classic gauche rotamer conformations, with the exception of χ4 in R84 corresponding to rotation of the guanidinium group. The rotamers of R84 tend to have stronger preference
for sampling a particular angle value than the rotamers of K82, making it overall less flexible. Moreover,
the guanidinium group of R84 is critical to the formation of the hydrophilic pocket of CypB, which makes
the pocket both more compact and well-formed. All of the residues with distinguishable torsions that lie
along loop region II, i.e., N102/104, T107/109, N108/110, and S110/112, are more restricted in motion
in CypB than in CypA, which may be coupled to the fixation of region II in CypB. The χ1 torsion of
L122/124 differs due to a variation in the structural role of the residue in each active site. In CypA, L122
forms loose hydrophobic interactions with the proline binding pocket in the apo enzyme with the side
chain rotating freely, but forms tight interactions with the target proline ring upon binding the substrate. However, in CypB, L124 has an essential role in the formation and shape of the proline binding
pocket which keeps the side chain in an upward position, consistently ready to interact with the substrate.
5.4

Characterization of intermolecular interactions and the effect of substrate dynamics on enzyme
function
A notable characteristic of how cyclophilin speeds up prolyl isomerization is by limiting the con-

formational freedom of the substrate. The active sites of cyclophilin PPIase domains make use of several
intermolecular hydrogen bonds with the substrate that form along the substrate peptide backbone. It is
well known that for CypA, R55 and N102 form hydrogen bonds with the substrate that are critical to
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substrate turnover.(13, 33, 42, 70, 198, 199) In addition to these, Q63 and W121 also participate in intermolecular hydrogen bonds, which also contribute to the binding affinity of the substrate to CypA. (35,
197, 199)This hydrogen bonding pattern is also fully conserved in the active site of CypB. The side chain
amine of Q63/65 forms a hydrogen bond with the carbonyl oxygen of the residue preceding the X-Pro
motif, near the N-terminus. N102/104 forms two hydrogen bonds: (1) from the backbone carbonyl oxygen of N102/104 to the backbone amine hydrogen of the X residue in the X-Pro motif and (2) from the
backbone amine hydrogen of N102/104 to the backbone carbonyl oxygen of the X residue in the X-Pro
motif. The guanidinium group of R55/57 forms a bifurcated hydrogen bond with the carbonyl oxygen of
the substrate proline. Lastly, the side chain amine group on the imidazole ring of W121/123 forms a hydrogen bond with the carbonyl oxygen of the residue following the X-Pro motif, near the C-terminus. We
have measured the probability of each hydrogen bond distance for CypA and CypB complexed to each of
the three configurations of substrate (Fig. 28). All of these hydrogen bonds are well formed when complexed to the transition state, which indicates one component of how both CypA and CypB proceed with
transition state stabilization. Also, hydrogen bonds tend to be better formed for the cis complex of cyclophilin as compared to the trans complex of cyclophilin, which can also contribute to cyclophilin having better affinity for the cis substrate over the trans. (13, 31, 67)
When the substrate is not bound to the enzyme, it can populate two transition states (ω = +90˚)
as it converts between the cis (ω = 0˚) and trans (ω = +180˚) conformers. Once the catalytic step proceeds, the cleft of the enzyme prevents the ω-bond from rotating freely and only positive ω-bond angle
values are sampled. We have used accelerated MD to sample the phi and psi torsional backbone angles
of the X-Pro substrate motif over five average simulations (Fig. 29). Accelerated MD allows for the enzyme-substrate complex to undergo cis/trans interconversion by making the cis and trans energetic
wells more shallow, thereby facilitating barrier transitions. When the substrate is not bound to the en
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Figure 28
Figure 28. Intermolecular hydrogen bonding pattern for CypA and CypB trans (red), transition state (green), and
cis (blue) enzyme-substrate complexes.
These include the hydrogen bonds formed by enzyme residues Arg 55/57, Gln 63/65, Asn 102/104, and Trp
121/123, for CypA/CypB respectively, with the participating atoms labeled in parentheses.
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Figure 29
Figure 29. Ramachandran space of substrate residues Ala and Pro sampled for the (A) free substrate, (B) CypA
complex, and (C) CypB complex, generated using accelerated MD.
Accelerated MD allows each enzyme complex to sample the trans, transition state, and cis conformations of the
substrate. Ala and Pro are consecutive in sequence, which make up the X-Pro motif recognized by cyclophilin. Energy levels are Boltzmann-weighted with a new contour line every 4.5 kcal/mol.
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zyme, it can sample both α-helical and β-sheet regions of Ramachandran space (Fig. 29A). For alanine of
the Ala-Pro motif, this includes both the left-handed and right-handed α-helical regions. Proline also
samples the β-sheet and right-handed α-helix conformations while unbound. However, when the substrate is bound to cyclophilin, the β-sheet region is preferred. For the CypA complex (Fig. 29B), the αhelical region can be sampled at higher energies, similar to the energies of the barrier height of the reaction. (41) In the CypB complex (Fig. 29C), the β-sheet region is more strictly sampled. It has previously
been suggested that the mechanism of all immunophilins involve specificity for the β-sheet substrate
conformation. (200)
The volume of the proline binding pocket was measured in both CypA and CypB for the apo enzyme and the enzyme-substrate complex with the substrate in the trans, cis, and transition state configurations using a previously established algorithm known as pocket volume measurer (POVME). Per this
calculation, the volume of the proline binding pocket rarely exceeds 100 Å3 (Fig. D11). This is a reasonable result since the volume of the proline ring is approximately 50 Å3. Volumes less than 10 Å3 occur
when the cavity becomes shallow. In apo cyclophilin, the proline binding pocket becomes shallow when
the stochastic dynamic motions of the residues cause the pocket to be ill-formed. Occasionally, the phenyl ring of F113/115, which forms the base of the pocket, flips outward approximately 90˚ to fill the
pocket. Other atoms of the active site residues occasionally drift8 toward the center of the proline binding pocket in the apo enzymes as well, such as the methyl group at the terminal end of M61/63 or the
imidazole side chain of H126/128. The concept of a shallow pocket can easily be conceived for the apo
enzymes, but not as easily for the bound trajectories which can also sample low pocket volumes. The
pocket volumes become shallow for the bound trajectories when the enzyme and substrate form strong
polar contacts in solution, but the nonpolar contacts are weak and near dissolution. Moreover, the proline ring can also lie roughly orthogonal to its classic orientation in the pocket where the rings of proline
and H126/128 lie on top of each other, which is also coupled with shallow pocket volumes. This is par-
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ticularly true in the cis complex of cyclophilin when the substrate analogue takes on a curved geometry
compared to the linear conformation of the trans substrate. The pocket tends to sample volumes larger
than expected when certain distortions cause the pocket not to be well formed, such as the side chains
of R55/57 or F60/62 being oriented away from the pocket.
5.5

Implications of CypA and CypB function in isoform-specific drug design
De novo drug design often makes use of compounds that are transition state mimics, since en-

zymes are known to be the most specific for the transition state. From analyzing the mechanisms of
CypA and CypB, transition state mimics would not be ideal for isoform-specific inhibition because both
enzymes optimize intermolecular interactions in essentially the same way, making use of several intermolecular hydrogen bonds and a mixture of hydrophobic and electrostatic contacts. Therefore, transition state mimics may be better suited for global cyclophilin inhibitors. These types of inhibitors tend to
cause the enzyme to optimize all of the intermolecular hydrogen bonds, as is the case when CypA binds
to cyclosporine A. (201) Our prior in silico study of cyclophilin inhibitors demonstrated that inhibitors
can successfully bind to all four conformational ensembles of CypA (i.e., apo, trans, transition state, and
cis). These results suggest that targeting a particular ensemble of conformations (e.g., the transition
state ensemble) may not impact inhibitor potency as well as exploitation of the enzyme mechanism can.
Theoretical and experimental studies have shown that if you can inhibit CypB as high potency,
then inhibition of CypA is also coupled; however, vice versa is not true. (123, 124) We have recently
studied the binding patterns of one of these inhibitors that binds with μM potency to bind both CypA
and CypB. (196) Two compounds, called compounds 1 and 2, from and experimental data set(123) of
cyclophilin inhibitors presents a case of isoform specificity. Only two functional groups are exchanged on
these two compounds, yet compound 1 gives 1000-fold binding selectivity to CypA over CypB and compound 2 inhibits both enzymes in the low μM regime at equilibrium. Our previous analyses involved
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compound 2 in CypA, but this leads to speculations on differences in the dynamics of CypA and CypB
that can rationalize these experimental results.
We have previously shown that compound 2 can interact with both the hydrophobic and hydrophilic pockets of CypA. The portions of compounds 1 and 2 that bind to the hydrophobic pockets are
identical, but the portion that interacts with the hydrophilic pocket differs by one functional group. On
compound 1, a nitro group is found on the functionalized phenyl ring while on compound 2 this is replaced with an amine group. Since a nitro group is about three times larger in mass than an amine
group, it is more feasible for the amine group to fit into the binding cavity. The hydrophilic pocket of
CypB is well formed, with the motion of R84 controlling the shape, while the hydrophilic pocket of CypA
can become more malformed. Since the hydrophilic pocket of CypA can become more misshapen (in
ways discussed above), it can accommodate larger functional groups in comparison to CypB. Moreover,
the hydrophilic pocket of CypB tends to become shallower when the guanidinium group of R84 blocks
the pocket, which also limits the effectiveness of binding to the cavity. Our results for the dynamics of
the binding cavities show that CypA has more flexibility while CypB is more rigid and limited in dynamic
motion in comparison. Compound 1 also has more rotatable bonds than compound 2, which affects the
entropic penalties of binding, and since CypB has a more rigid binding cavity it might require inhibitors
that have less rotatable bonds. The rigidity of the CypB active site suggests that small, rigid inhibitors are
suitable for CypB knockdown, and could be the reason why CypB requires a higher concentration of CsA
to reach IC50 and has a slightly lower turnover number.
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CONCLUSIONS
Molecular dynamics simulations of substrate-free CypA and the enzyme-substrate complexes

when the substrate is in the trans, transition state, and cis configurations were carried out to determine
the relevant conformational changes and intermolecular interactions that impact catalysis. The dynamics of active site residues of the substrate-bound CypA complexes are inherent in the substrate-free enzyme. Variations in the electrostatic and hydrophobic contacts are observed as the configuration of the
substrate changes in the active site during catalysis. Presence of the substrate in the active site impacts
the dynamics of certain key active site residues and loop regions of the enzyme. CypA stabilizes the transition state by forming optimized hydrophobic and electrostatic interactions with the substrate, making
use of a pre-organized network of hydrogen bonds. These hydrogen bonds form and break with ease in
the ground states, but remain tightly formed in the transition state, localizing the enzyme conformations
of the transition state to a relatively small conformational space. The enzyme therefore binds the substrate in the transition state configuration more tightly than the substrate in the cis state, followed by
the substrate in the trans state. The hydrogen-bonding interaction that is formed between Arg 55 and
the substrate is responsible for a large portion of the electrostatic interaction. This study provides general atomistic insight into the interplay among enzyme conformational dynamics, recognition, and catalysis.
Although a growing body of experimental data suggests that enzyme motions play an important
role in its catalytic function, the exact nature of this dynamical contribution has never been explained
earlier. Here, we show that substrate dynamics involved in the chemical step are coupled to the dynamics of the surrounding medium, which can either be the solvent or the active site of the enzyme. If the
environment relaxes much faster than the chemical step such that there is a clear separation of timescales, the motions are not coupled; e.g., second-timescale cis-trans isomerization in aqueous solution
occurs much slower than the relaxation of solvent molecules. Provided the timescale of the chemical
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step falls within that of the fluctuations in the environment, the motions on the same timescale as well
as those that are slightly faster and slower than the chemical step get coupled to substrate dynamics
and result in multi-exponential kinetic decays. Since our studies were carried out in the regime of lower
free-energy barriers in which the timescale of substrate dynamics was shifted to nanoseconds, we could
observe the coupling with nanosecond motions of the enzyme. But for the actual cis-trans isomerization
that involves larger barriers and takes place in milliseconds in CypA, increasingly slower modes of the
enzyme clustered in the millisecond-timescale will be selected for coupling with substrate dynamics. We
further show that one-dimensional Kramers’ theory in the high friction regime, which has proved sufficiently valid in analyzing and explaining the kinetics of various problems of biological interest (which includes protein folding (202-205) and cis-trans isomerization in peptides (94, 98)) can be equally useful to
interpret the kinetics of enzyme-catalyzed chemical step and understand the role of enzyme dynamics.
The enzymatic motions do not and cannot modify the free energy landscape of the enzyme-substrate
complex, but rather reduce the effective diffusion coefficient as compared to the reference nonenzymatic reaction in solution. These effects that are incorporated in the pre-exponential factor of the
chemical reaction reduce the speedup possible from barrier effects alone and, as we show, modify the
diffusion coefficient by more than an order of magnitude. Therefore, as often implied, enzyme dynamics
do not accelerate the chemical step. Enzymatic motions are important for reorganization of the active
site so that the transition state is better stabilized. However, enzyme dynamics does not have to enhance the catalytic rate to be important to the chemical step. Perturbation of conformational motions
caused by mutations or acceleration affects the catalytic rate, resulting from modification of both the
free energy profile and the effective diffusion coefficient. In any case, it is the alteration of free-energy
barriers that remains the dominant effect in either impeding or enhancing catalytic rates. Our results
provide the missing link between assertions made from theoretical studies and observations from experimental studies, thereby unifying disparate views about the role of enzyme dynamics in catalysis.
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The conformations of an enzyme can vary considerably as its substrate goes from the reactant
state through the transition state to the product state. The results of our molecular dynamics simulations and principal component analysis reveal that the binding site of CypA recognizes the peptide substrate analogue in the trans, transition state, and cis configurations mainly via conformational selection.
Moreover, the enzyme transition state ensemble of conformations exhibit less conformational fluctuation than any other ensemble and is the least populated by the free enzyme. Inhibitors of CypA were
shown to bind more favorably to enzyme conformations that are similar to those of the cis and transition state complexes. Our inhibitor studies reveal the importance of the polar pocket in human CypA
and the occupied water molecules in designing potent inhibitors. These results allow us to argue that
the enzyme cis and transition state ensembles contain the most relevant conformations for developing
and optimizing selective inhibitors in structure-based drug design.
We use several methods to probe differences in intramolecular and intermolecular interactions
between CypA and CypB at the enzyme backbones and binding sites. The dominant motion of the CypA
backbone samples global displacements over the enzyme structure, while the dominant motion of the
CypB backbone is very rigid and only samples significant flexibility in the less dominant motions. The
backbone motions of apo CypA are most preserved by the trans complex of CypA and least preserved by
the cis complex of CypA, while the transition state reflects intermediate preservation of apo CypA backbone motions. The backbone motions of apo CypB are most preserved by the cis complex of CypB and
least preserved by the trans and transition state complexes of CypB. The residues that contribute to flexibility and fixation varies per enzyme and also varies along the catalytic step.
Notable dynamics captured in our simulations involve several loop regions on the solvent accessible surface of cyclophilin, in addition to key active site residues. We have characterized these surface
loops as loop region I-IV, and have found that loop regions II and IV have opposite dynamics in CypA and
CypB. The opposing dynamics found in loop regions II and IV are due to intramolecular salt bridges

106
found in CypB that are not present in CypA. This finding demonstrates that changes in primary sequence
(as found in loop regions II and IV) can lead to variation in dynamics between two enzyme isoforms.
The shape of the CypA active site cavity is modulated as the enzyme catalyzes the substrate
from the ground state to the transition state, with the transition state complex characterized by narrower, tighter pocket shapes. This occurs due to optimization of intermolecular hydrogen bonds and
hydrophobic contacts with the substrate, drawing all of the active site residues near the substrate.
However, in CypB, the cavity shape of the active site stays approximately the same when bound to the
substrate, regardless of the substrate conformation. Key active site residues whose motions shift the
sampling of conformational sub-populations include R55/57, F60/62, N102/104, and A103/105, for
CypA/CypB respectively. Motions in R55/57 are connected to all of the conformational ensembles. Motions in F60/62 tend to be linked to the transition state and cis conformational ensembles. Due to the
opposing dynamics of loop region II in CypA and CypB, motions in N102/104 and A103/105 vary along
the catalytic step of each enzyme, which can regulate hydrogen bonding by N102/104.
The hydrophilic pocket that we have shown to interact with cyclophilin inhibitors also exhibits
dynamics which are sensitive to the conformation of the substrate. In CypA, K82 has notable flexibility in
the trans and cis complexes and has significant impact on the formation of the hydrophilic cavity. The
side chain of K82 needs to be oriented toward the cavity for it to have a well-formed shape. In addition
to this, the flexibility introduced into loop region II by CypA binding the substrate causes the hydrophilic
pocket to break a well-formed shape. The hydrophilic cavity shape of CypB is also regulated by the motion of R84 (analogous to K82 in CypA) in the same way, but tends to remain a better formed pocket
since R84 has better intramolecular electrostatic interaction and less torsional freedom than its analogous counterpart. The fixation of loop region II upon CypB binding the substrate also contributes to a
better formed pocket. Both the hydrophobic and hydrophilic cavities of CypB tend to be more well-
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formed over the reaction coordinate in comparison to CypA, reflected by the torsional angles of the
CypB active site being either the same as or more restricted in motion than those of the CypA active site.
The intermolecular interactions that form between cyclophilin and the substrate involve several
hydrogen bonds that form between the substrate backbones and the active site residues, as well as the
formation of van der Waals contacts as the proline is desolvated. This is consistent in both CypA and
CypB, and both enzymes undergo transition state stabilization in the same way. However, CypB restricts
substrate motion to a greater extent than CypA does. CypB restricts the Ala-Pro motif of the substrate to
the β-sheet region of Ramachandran space, although CypA can sample α-helical regions of Ramachandran space at higher energies. Polar interactions have a stronger effect on the binding affinity of the
substrate than non-polar interactions; therefore, the cyclophilin complex can still be well-formed even
when the proline binding pocket samples volumes which cannot fully accommodate the proline ring.
Developing inhibitors to discriminate between CypA and CypB involves taking advantage of highlighted
differences in dynamics, binding affinities, and topological structure.
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APPENDICES
Appendix A: Supporting Figures for Chapter 2

Figure A1
Figure A1. Probability distributions of side chain torsional angles of active site residues of CypA for the substrate-free enzyme (black) and the enzyme-substrate complexes when the substrate is in the trans (red), transition state (green), and cis (blue) configurations.
Note that for residues containing rings, the motion of χ2 also corresponds to the motion of the ring. The torsional
angle of χ3 is defined by the side chain atoms Cβ-Cγ-Cδ-Nε. Likewise, the torsional angle of χ4 is defined by the
side chain atoms Cγ-Cδ-Nε-Cζ.
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Figure A2
Figure A2.Three-dimensional plot of the top three principal components of the motions of the active site residues in two different orientations, (A) and (B), for the substrate-free enzyme (black) and the enzyme-substrate
complexes when the substrate is in the trans (red), transition state (green), and cis (blue) configurations.

126

Figure A3
Figure A3. Scree plot for the top ten principal components of the motions of the active site residues of CypA.
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Figure A4
Figure A4. Probability distributions of hydrogen bond distances from the four independent simulations of all of
the substrate-bound CypA complexes.
Each row represents a different intermolecular enzyme-substrate hydrogen bond measured from a heavy atom to
another heavy atom when the substrate is in the trans (red), transition state (green), and cis (blue) configurations.
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Appendix B: Supporting Figures for Chapter 3

Figure B1
Figure B1. Accelerated MD increases the dynamics in CypA active site. Structure of CypA (gray) is shown with its
active site residues in stick representation.
2

The ten active site residues are colored (see color scale) according to S values (SI Text, section 1.8) obtained from
(A) nMD and (B) aMD for their specific side-chain bond vectors indicated in brackets as follows: Arg55 (NE-CZ
bond), Phe60 (CA-CB bond), Met61 (CG-SD bond), Gln63 (CG-CD bond), Ala101 (CA-CB bond), Asn102 (CG-ND2
bond), Ala103 (CA-CB bond), Phe113 (CA-CB bond), Leu122 (CG-CD1 bond), His126 (CA-CB bond).
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Figure B2
Figure B2. Accelerated MD increases the conformational heterogeneity and plasticity in free CypA as compared
to normal MD.
Shown here are the probability distributions of selected side-chain dihedrals of eight active site residues and Ser99
obtained from normal MD (black) and accelerated MD at the lowest (blue), intermediate (green), and the highest
(red) level of acceleration.
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Figure B3
Figure B3. Potentials of mean force form umbrella sampling.
The plot shows the free energy profiles as a function of ω dihedral represented as potentials of mean force obtained from umbrella sampling for the cis-trans isomerization in the free (solid lines) and the CypA-bound (dasheddotted lines) substrate using V2 of 9.0 (blue) and 11.0 (red) kcal/mol.
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Figure B4
Figure B4. Free energy profiles obtained after reweighting the distributions from accelerated MD.
Shown are the free energy profiles for the cis-trans isomerization in the free (bold black) and the enzyme-bound
(bold red) substrates with upper and lower bounds of errors (thin lines). For these simulations, V2 for ω-bond rotation was set to the reoptimized value of 28 kcal/mol.
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Figure B5
Figure B5. No significant differences in the distribution of backbone dihedrals of active site residues in the free
and the bound CypA.
Shown are the Ramachandran (φ – ψ) plots of ten active site residues obtained from normal MD simulations of
free CypA (Co) (black) and CypA bound to the substrate Ace-Ala-Ala-Pro-Phe-Nme in which Ala-Pro ω-bond sampled either the trans (Ctrans) (blue), transition state (CTS) (green) or cis (Ccis) (red) configurations. The φ – ψ space
sampled by active site residues of the free and the bound enzyme are very similar.
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Figure B6
Figure B6. Side-chain conformational redistribution in CypA bound to the substrate in the trans, transition state,
and cis configurations.
Shown are the probability distributions of selected side-chain dihedrals of active site residues and Ser 99 obtained
from normal MD simulations of Co (black), Ctrans (blue), CTS (green), and Ccis (red). The x-axis scale is the same as in
Fig. B1.
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Figure B7
Figure B7. Backbone amide bond fluctuations show no significant differences between the free and the bound
CypA across the entire length of CypA.
2

The S NH values for the free CypA (black), Ctrans (blue), CTS (green), and Ccis (red) calculated (section 3.6.8) from the
respective normal MD simulations are plotted vs. residue numbers in three panels (A, B, C).
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Figure B8
Figure B8. Fluctuations of side-chain bonds of some active site residues show marked differences in the free and
bound enzyme.
2

Order parameters (S ) for side-chain bond vectors of polar residues are shown in blue: Arg55 (NE-CZ bond) (blue
filled circles), Gln63 (CG-CD bond) (blue filled triangles), Asn 102 (CG-ND2 bond) (blue circles), His 126 (CA-CB
bond) (blue filled squares); Data for nonpolar residues are shown in black and red: Phe60 (CA-CB bond) (black filled
circles), Met61 (CG-SD bond) (black filled squares), Ala101 (CA-CB bond) (black filled triangles), Ala103 (CA-CB
bond) (red filled triangles), Phe113 (CA-CB bond) (red filled circles), Leu122 (CG-CD1 bond) (black circles).
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Appendix C: Supporting Figures for Chapter 4

Figure C1
Figure C1. Validation of AutoDock Vina by re-docking compound B into the active site of CypA.
(A) The conformation of compound B (green) in the active site of CypA in the crystal structure with PDB ID 3RDD
was reproduced after carrying out flexible docking of compound B (red) into the active site of the same single crystal structure using AutoDock Vina. (B) Flexible docking of compound B using AutoDock Vina into the active site of
CypA using an ensemble of conformations of CypA that was obtained using molecular dynamics. The most probable binding mode of compound B in the active site of CypA is identical to the binding mode in the crystal structure.
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AppendixD: Supporting Figures for Chapter 5

Figure D1
Figure D1. Residue numbers corresponding to CypA backbone regions showing significant displacements in IED
results.
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Figure D2
Figure D2. Residue numbers corresponding to CypB backbone regions showing significant displacements in IED
results.
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Figure D3
Figure D3. Cross-correlation maps for the correlation between α-carbons of all enzyme residues contained in
CypA.
(A) is for the apo conformation of CypA. (B) is for CypA complexed to the trans configuration of the substrate. (C)
is for CypA complexed to the transition state configuration of the substrate. (D) is for CypA complexed to the cis
configuration of the substrate. Positive correlations are highlighted in red, negative correlations in blue, and the
zero point in white.
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Figure D4
Figure D4. Structural representation of positively correlated enzyme regions for CypA (off-diagonal).
Structure 1 shows enzyme residues 5-17 (pink) and 152-164 (light blue). Structure 2 shows enzyme residues 143162 (lime) and 39-42, 48-53, 55-58 (purple). Structure 3 shows enzyme residues 17-29 (yellow) and 129-137 (orange). Structure 4 shows enzyme residues 34-39 (royal blue) and 77-78 (red). Structure 5 shows enzyme residues
59-65 (cyan) and 110-118 (brown).
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Figure D5
Figure D5. Structural representations of the enzyme regions showing distinctive negative correlation on the
cross-correlation maps.
Structure A shows enzyme residues 7-16 (purple) and 110-117 (yellow). Structure B shows enzyme residues 10-17
(green) and 65-74 (orange). Structure C shows enzyme residues 50-57 (blue) and 65-74 (orange). Structure D
shows enzyme residues 65-74 (orange) and 147-157 (red). Structure E shows enzyme residues 102-115 (pink) and
147-157 (red). These regions are relevant for CypA in the apo state and complexed to the substrate in the ground
states, i.e., trans and cis states.
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Figure D6
Figure D6. Cross-correlation maps for the correlation between α-carbons of all enzyme residues contained in
CypB.
(A) is for the apo conformation of CypB. (B) is for CypB complexed to the trans configuration of the substrate. (C) is
for CypB complexed to the transition state configuration of the substrate. (D) is for CypB complexed to the cis configuration of the substrate. Positive correlations are highlighted in red, negative correlations in blue, and the zero
point in white.
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Figure D7
Figure D7. Significant motions of the hydrophobic cavity contributing to the conformational spread sampled by
the active site of CypA.
(A) R55 can sample upward and downward conformations. (B) The phenyl ring of F60 can shift from being pointed
inward, toward the substrate to either being parallel with the substrate or (C) to being pointed outward, away
from the substrate. (D) Loop region II, which contains active site residues A101, N102, and A103, can shift from
being pointed downward as found in the crystal structure to either becoming twisted such that the loop is parallel
with substrate or (E) sampling deviations that create kinks in the loop that also displace these residues.

144

Figure D8
Figure D8. Significant motions of the hydrophilic cavity contributing to the conformational spread sampled by
CypA and CypB.
(A) K82 in CypA shifts from being outward, away from the cavity to being inward, promoting a well formed cavity.
(B) Loop region II is normally pointed downward, but can point upward as CypA catalyzes the substrate, which disrupts the structure of the hydrophilic pocket. (C) E81 in CypA can shift from being pointed outward, away from the
cavity, to moving inward by forming stronger intramolecular interaction. (D) R84 in CypB can shift from being
pointed outward, disrupting the shape of the pocket, to being pointed inward promoting a well-formed hydrophilic
pocket.
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Figure D9
Figure D9. Torsional angles of residues in the hydrophobic and hydrophilic pockets of CypA that are distinguishable from CypB.
The data for apo CypA is shown in black, along with CypA complexed to the trans (red), transition state (green),
and cis (blue) substrate configurations.

146

Figure D10
Figure D10. Torsional angles of residues in the hydrophobic and hydrophilic pockets of CypB that are distinguishable from CypA.
The data for apo CypB is shown in black, along with CypB complexed to the trans (red), transition state (green),
and cis (blue) substrate configurations.
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Figure D11
Figure D11. Volume measurements of the hydrophobic pockets of CypA and CypB calculated with the POVME
algorithm.
Data is shown for apo Cyp (black), along with Cyp complexed to the substrate in the trans (red), transition state
(green), and cis (blue)configurations. Volumes are generated for three independent simulations of each bound
enzyme ensemble and one continuous 300 ns ensemble for apo Cyp.
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Figure D12

Figure D12. Scree plots for all PCA data.

